ANTIOCH, Tenn., July 02, 2026 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) will release its second quarter 2026 financial results on Thursday, July 30, 2026.
Conference Call Details
LKQ will host a conference call and webcast on July 30, 2026 at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) with members of senior management to discuss the Company's results. To access the investor conference call, please dial (833) 461-5787. International access to the call may be obtained by dialing (626)884-3620. The investor conference call will require you to enter conference ID:434311175.
Webcast and Presentation Details
The audio webcast and accompanying slide presentation can be accessed at (www.lkqcorp.com) in the Investor Relations section.
An online replay of the audio webcast will be available on the Company's website and can be accessed through the Investor Relations section, investor.lkqcorp.com under “Events”. Please allow approximately two hours after the live presentation before attempting to access the replay.
About LKQ Corporation
LKQ Corporation (www.lkqcorp.com) is a leading provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles. LKQ has operations in North America, Europe and Taiwan. LKQ offers its customers a broad range of OE recycled and aftermarket parts, replacement systems, components, equipment, and services to repair and accessorize automobiles, trucks, and recreational and performance vehicles.
Contact
Joseph P. Boutross
LKQ Corporation
Vice President, Investor Relations
(312) 621-2793 [email protected]
Key Takeaways S&P 500, Nasdaq and Dow posted their strongest Q2 performances in years amid broad market gains.MU, WDC, MCHP, CRDO and STRL are highlighted as momentum picks for Q3 2026.AI infrastructure demand across memory, storage, connectivity and data centers support these stocks. U.S. stock markets closed an impressive second-quarter 2026. The S&P 500 and the Nasdaq Composite rallied 14.9% and 21.4% respectively, to post their best second-quarter performance since 2020. The Dow advanced 12.9%, marking its strongest quarter since the fourth quarter of 2022.
Momentum Likely to Continue in Q3AI trade is gathering steam as days progress. AI infrastructure trade is now expanding from chips to memory and storage devices as well as servers and racks. Moreover, agentic AI is expanding the scope of AI infrastructure providers in the physical layer.
Massive AI data center growth is benefiting several nuclear power generator and reactor makers, construction giants, cooling and water purifying companies and industrial manufacturers.
On May 28, the U.S. government entered into a "memorandum of understanding" with Iran to extend the ceasefire for 60 days and continue negotiations on the latter’s nuclear program. The negotiations include the reopening of the Strait of Hormuz with Iran removing its mines within 30 days and the United States gradually lifting the naval blockade.
At this stage, we recommend five stocks with a favorable Zacks Rank that are expected to maintain their momentum in the third quarter, too. These are: Micron Technology Inc. (MU - Free Report) , Western Digital Corp. (WDC - Free Report) , Microchip Technology Inc. (MCHP - Free Report) , Credo Technology Group Holding Ltd. (CRDO - Free Report) and Sterling Infrastructure Inc. (STRL - Free Report) .
Each of the stocks sports a Zacks Rank #1 (Strong Buy) at present and has a Zacks Momentum Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.
The chart below shows the price performance of our five picks in the past three months.
Image Source: Zacks Investment Research
Micron Technology Inc.Micron has been benefiting tremendously from the enormous application of AI in day-to-day life, which has pushed up the demand for memory chips. The four major hyperscalers raised their AI capital expenditure budget to $750 billion for 2026. This figure is set to cross $1 trillion next year and is likely to rise further beyond 2027.
This has resulted in more AI semiconductor sales implying the need for multiple AI memory chips to operate. Flash memory technologies like DRAM and NAND are used in AI chips, enabling them to perform optimally.
This has pushed up the demand for AI-enabled memory chips. In their last earnings reports, all four major hyperscalers highlighted a shortage of memory and storage chips, resulting in soaring prices of these products. As a result, MU benefits significantly.
Micron has meaningful exposure to AI, cloud data centers, industrial IoT and autonomous vehicles, all of which require increasingly advanced memory solutions. As AI adoption accelerates, demand for DRAM and NAND products continues to rise.
MU has invested heavily in next-generation memory technologies, positioning itself to meet the growing performance and efficiency requirements of AI systems. A particularly important growth driver is high-bandwidth memory (“HBM”), which has become essential for advanced AI workloads. Micron Technology’s HBM3E and HBM4 products are seeing exceptionally strong demand because they offer the speed and efficiency required by modern AI systems.
MU’s position in the AI ecosystem continues to strengthen. NVIDIA identified Micron as a key HBM supplier for its GeForce RTX 50 Blackwell GPUs, reinforcing its importance within the AI supply chain. Demand for HBM4 is also benefiting from next-generation AI infrastructure deployments, including NVIDIA’s Vera Rubin platform.
Micron has an expected revenue and earnings growth rate of more than 100% each, for the current year (ending August 2026). The Zacks Consensus Estimate for the current year’s earnings has improved 16.3% in the last seven days.
Western Digital Corp.Western Digital has been witnessing strong execution amid intensified cloud and AI demand. WDC saw strong data center demand and increased adoption of high-capacity hard disk drives. This reflects its ability to scale reliable, high-capacity storage solutions to meet the needs of the AI-driven data economy.
As AI and cloud adoption accelerate, demand for higher-density storage continues to rise. WDC is meeting this demand through close collaboration with hyperscalers, delivering reliable, high-capacity drives at scale with strong performance and total cost of ownership.
Western Digital has an expected revenue and earnings growth rate of 38.1% and 82.3%, respectively, for the current year (ending June 2027). The Zacks Consensus Estimate for the current year’s earnings has improved 6.6% over the last 30 days.
Microchip Technology Inc.Microchip Technology benefits from growing AI investments. The company’s Gen 4 and Gen 5 data center products are witnessing strong sales growth. MCHP’s new products are expected to gain traction with the launch of the industry's first 3-nanometer-based PCIe Gen 6 switch that powers modern AI infrastructure.
These switches offer double bandwidth, lower latency, advanced security and high-density AI connectivity for next-generation cloud and data center performance. The success of the restructuring plan also bodes well for MCHP’s prospects. The company also entered the PCIe retimer market in the June 2026 quarter as a companion device for Gen6 switches, and disclosed an OEM design win that displaced a competitor.
MCHP has expanded connectivity, storage and compute offerings for AI and data center applications, as well as intelligent power modules for AI at the edge. These factors are expected to drive top-line growth in the long term.
Microchip Technology has an expected revenue and earnings growth rate of 31.7% and 88.4%, respectively, for the current year (ending March 2027). The Zacks Consensus Estimate for the current year’s earnings has improved 0.3% in the last 30 days.
Credo Technology Group Holding Ltd.Credo Technology is a provider of high-performance serial connectivity solutions for the hyperscale datacenter, 5G carrier, enterprise networking, artificial intelligence and high-performance computing markets.
CRDO’s outlook is supported by widening AEC adoption, rising hyperscaler and Neo cloud traction, and a larger optical portfolio that now includes silicon photonics PIC technology following the DustPhotonics acquisition. AECs remain the primary growth engine as they play an increasingly critical role in AI-driven networking deployments.
ZF Optics is moving from initial ramp to a broader fiscal 2027 revenue contributor. The acquisition of Dust Photonics strengthens CRDO’s high-speed optical connectivity portfolio with silicon photonics PIC technology.
The deal adds advanced technology, including 800G and 1.6T solutions, and would aid in developing upcoming 3.2T solutions. CRDO projects more than $600 million in optical revenues, with ZeroFlap optics, silicon photonics PICs and optical DSPs each contributing more than $100 million in fiscal 2027.
Credo Technology has an expected revenue and earnings growth rate of 75.8% and 72.8%, respectively, for the current year (ending March 2027). The Zacks Consensus Estimate for the current year’s earnings has improved 17.5% in the last 30 days.
Sterling Infrastructure Inc.Zacks Rank #1 Sterling Infrastructure specializes in constructing complex data centers, e-commerce distribution facilities, and manufacturing sites. The company is a major provider of high-density, AI-Powered data centers. STRL is a notable beneficiary of the massive AI data center boom.
E-Infrastructure Solutions projects develop advanced, large-scale site development systems and services for data centers, e-commerce distribution centers, warehousing, transportation, energy and more.
Sterling’s combined offering of site development and electrical services is gaining traction faster than expected. STRL highlighted that in the first quarter of 2026, two data center campuses moved to integrated execution six to eight months earlier than planned, validating cross-sell traction and schedule compression benefits.
STRL’s complementary investments — AI tools that increased project manager capacity by about 15% and a modular manufacturing program that will triple capacity within nearly 18 months — reduce field labor intensity and enhance quality/efficiency.
Sterling Infrastructure has an expected revenue and earnings growth rate of 59.2% and 75.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 2.1% over the last 30 days.
CHESAPEAKE, Va.--(BUSINESS WIRE)--Dollar Tree, Inc. (NASDAQ: DLTR) (the “Company”) today announced that its Board of Directors has replenished the Company’s share repurchase authorization to an aggregate amount of $2.5 billion, consistent with the authorization limit previously approved by the Board in July 2025. This new reauthorization includes any amounts remaining under the Company’s pre-existing program.
As recently announced, the Company repurchased $500 million of its common stock in June 2026 as part of a block trade involving selling stockholders including certain funds affiliated with Mantle Ridge LP. Following that transaction, the Company had approximately $700 million remaining under its existing $2.5 billion authorization.
"The replenishment of our share repurchase authorization reinforces our commitment to disciplined capital allocation and reflects our confidence in Dollar Tree's long-term growth," said Michel C. Creedon, Jr., Chief Executive Officer. "We remain focused on investing in strategic initiatives that support sustainable growth, maintaining financial strength and flexibility, and returning excess capital to shareholders over time.”
The Board’s authorization permits the Company to repurchase shares of its common stock from time to time in the open market or through privately negotiated transactions, subject to market and other conditions, up to the aggregate amount authorized by the Board. The Board’s authorization has no expiration date.
About Dollar Tree, Inc.
Dollar Tree, Inc., headquartered in Chesapeake, VA, is one of North America’s largest and most loved value retailers, known for delivering great value, convenience, and a “thrill-of-the-hunt” discovery shopping experience. With a team of approximately 150,000 associates, Dollar Tree operates more than 9,300 stores and 19 distribution centers across 48 contiguous states and seven Canadian provinces under the brands Dollar Tree and Dollar Tree Canada. The Company is committed to being a responsible steward of its business – supporting its people, serving its communities, and creating lasting value. To learn more about the Company, visit www.DollarTree.com.
A WARNING ABOUT FORWARD-LOOKING STATEMENTS: This press release contains "forward-looking statements" as that term is used in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they address future events, developments or results and do not relate strictly to historical facts. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements preceded by, followed by or including words such as: “believe”, “anticipate”, “expect”, “intend”, “plan”, “view”, “target” or “estimate”, “may”, “will”, “should”, “predict”, “possible”, “potential”, “continue”, “strategy”, and similar expressions. For example, our forward-looking statements include statements regarding our plans and expectations concerning share repurchases, capital allocation, strategic and other growth initiatives, cash flow and other objectives and expectations. These statements are subject to risks and uncertainties. For a discussion of the risks, uncertainties and assumptions that could affect our future events, developments or results, you should carefully review the “Risk Factors,” “Business” and “Management's Discussion and Analysis of Financial Condition and Results of Operations” sections in our Annual Report on Form 10-K filed March 16, 2026, our Quarterly Report on Form 10-Q for the most recently ended fiscal quarter, and other filings we make from time to time with the Securities and Exchange Commission. We are not obligated to release publicly any revisions to any forward-looking statements contained in this press release to reflect events or circumstances occurring after the date of this report and you should not expect us to do so.
Dollar Tree, Inc. (NASDAQ: DLTR) (the âCompanyâ) today announced that its Board of Directors has replenished the Company's share repurchase authorization t
CAMBRIDGE, Mass., July 02, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies, Inc. (NASDAQ: AKAM) announces the company has completed its acquisition of secure enterprise browser provider and AI usage control leader LayerX. On May 14, Akamai announced an agreement between the two parties for Akamai to acquire LayerX in exchange for approximately US$205 million.
LayerX offers a browser security platform that allows enterprises to add protections to their preferred, existing browsers. It enables security teams to have greater visibility into how users interact with web content, prompts, file uploads, and SaaS applications both within and outside the browser. The acquisition will build on Akamai’s investment in its Zero Trust platform, which includes market-leading segmentation, Zero Trust Network Access (ZTNA), and DNS security solutions, already trusted by thousands of global customers. By leveraging Akamai’s massive, globally distributed network, the combined solution will create a workforce security solution that addresses a need to govern and secure how employees, partners, and supply chain ecosystems interact with AI applications.
For more information, visit the Akamai Zero Trust solutions page.
About Akamai
Akamai is the cybersecurity and cloud computing company that powers and protects business online. Our market-leading security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. Akamai’s full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. Global enterprises trust Akamai to provide the industry-leading reliability, scale, and expertise they need to grow their business with confidence. Learn more at akamai.com and akamai.com/blog, or follow Akamai Technologies on X and LinkedIn.
Akamai Statement Under the Private Securities Litigation Reform Act
This press release contains statements that are not statements of historical fact and constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about product success and other benefits of the transaction to Akamai. Each of the forward-looking statements is subject to change as a result of various important factors, many of which are beyond Akamai’s control, including, but not limited to: Akamai’s inability to achieve the expected benefits of the transaction; challenges integrating LayerX’s business, employees, and technology; and effects of competition. The forward-looking statements contained herein are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, Akamai disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group reminds investors of a class action lawsuit against Hub Group, Inc. (“Hub Group” or “the Company”) (NASDAQ: HUBG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of HUBG during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: April 28, 2023 to May 11, 2026
DEADLINE: August 28, 2026
CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Multiple Hub Group financial statements from 2023 and 2024 including its annual reports included material misstatements on multiple topics including revenue recognition and operating income. The Company’s financial statements from Q1 2025 to Q3 2025 contained other misstatements. Based on these facts, Hub Group’s public statements were false and materially misleading throughout the class period.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
Join the case to recover your losses.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
[url="]The DJS Law Group[/url] reminds investors of a class action lawsuit against Hub Group, Inc. (âHub Groupâ or âthe Companyâ) (NASDAQ: [url="]HUBG[/
, /PRNewswire/ -- Hub Group, Inc. (NASDAQ: HUBG) and certain of its current and former executives (together, "co-defendants") face a securities class action lawsuit, which seeks to represent investors who purchased or acquired Hub Group securities between April 28, 2023 and May 11, 2026.
The development follows the company's surprise revelations that its financial reports going back to 2023 were "materially misstated and should no longer be relied upon" and corrective actions taken against two senior executives.
National shareholder rights firm Hagens Berman continues to investigate legal claims that Hub Group and its co-defendants violated the federal securities laws and urges investors who suffered significant losses to submit your losses now.
Class Period: Apr. 28, 2023 – May 11, 2026
Lead Plaintiff Deadline: Aug. 28, 2026
Visit: www.hbsslaw.com/investor-fraud/hubg
Contact the Firm Now: [email protected]
844-916-0895
Hub Group, Inc. (HUBG) Securities Class Action:
The lawsuit focuses on the propriety of Hub Group's repeated assurances that its financial statements were prepared in conformity with applicable accounting rules.
Contrary to these assurances, the complaint alleges that throughout the Class Period the co-defendants made false and misleading statements concerning Hub Group's premature and incorrect revenue recognition and understatement of purchased transportation costs and accounts payable.
Investors learned the truth through a series of Hub Group's partial disclosures about its accounting and ramifications for certain of its executives.
First, on February 6, 2026, investors saw the price of their Hub Group shares crater $9.37 (-18%) after the company (while touting that "[a]ccuracy and transparency in reporting on our performance is of utmost importance[]") revealed that during the first nine months of 2025 it had understated purchased transportation costs and accounts receivable by $77 million. Accordingly, the company said investors should not rely on its Q1 – Q3 2025 financial statements and it plans to restate them.
Second, on May 12, Hub Group shares tumbled again – this time, shares fell $5.24 (-12.5%) – on new disclosures much worse than on February 6. The company said its financial statements for the years ended December 31, 2023 and 2024 were materially misstated and that investors should no longer rely on those either. Hub Group explained only that it "identified certain transactions that were prematurely or incorrectly recognized or not adequately supported[]" and cautioned it was continuing to review "additional accounting issues that may potentially further impact" the 2023 and 2024 financial statements.
Between February 5, 2026 (the day before Hub Group's first partial corrective disclosure) and May 12, 2026, shareholders have seen over $890 million of Hub Group's market capitalization wiped out.
After the Class Period, on June 2, 2026, Hub Group announced that Chief Financial Officer Kevin Beth and Chief Operating Officer Brian Meents both left the company on May 27. The company said the executive departures were part of its corrective actions related to its financial statement review.
"Now that Hub Group has almost cleaned out its C-suite following accounting improprieties reaching all the way back to 2023, the core focus of our investigation is whether they were intentional or reckless with the goal of making financial metrics appear better than they actually were. We're also looking to see whether additional problems will surface when the company's review is completed," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.
If you invested in Hub Group and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »
If you'd like more information and answers to other frequently asked questions about the Hub Group case and the firm's investigation, read more »
Whistleblowers: Persons with non-public information regarding Hub Group should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
Boston, Massachusetts--(Newsfile Corp. - July 2, 2026) - Block & Leviton announces that a securities fraud lawsuit has been filed against Hub Group, Inc. (NASDAQ: HUBG) and certain of its executives. Investors who have lost money in their Hub Group investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/hubg.
What is this all about?
The complaint alleges that Hub Group, a North American transportation and logistics company, told investors during the class period that its financial reports were accurate and that its internal accounting controls were effective. According to the complaint, the Company had actually been recognizing certain transactions too early or incorrectly and had understated its purchased transportation costs and accounts payable, making its reported revenue, expenses, and operating income materially wrong. The truth began to emerge on February 5, 2026, when Hub Group announced it would restate its financial statements for the first three quarters of 2025 due to a roughly $77 million understatement, and again on May 12, 2026, when it disclosed that its 2023 and 2024 annual reports were also materially misstated and should no longer be relied upon. Following these announcements, Hub Group's stock price fell sharply, dropping about 18% in February 2026 and a further 13% in May 2026.
Who is eligible?
Anyone who purchased Hub Group, Inc. common stock between April 28, 2023, and May 11, 2026, and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What should you do next?
The deadline to seek appointment as lead plaintiff is August 28, 2026. A class has not yet been certified, and until a certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (888) 256-2510.
Whistleblower?
If you have non-public information about Hub Group, Inc., you should consider assisting in our investigation or working with our attorneys to file a report with the Securities Exchange Commission under their whistleblower program. Whistleblowers who provide original information to the SEC may receive rewards of up to 30% of any successful recovery. For more information, contact Block & Leviton at [email protected] or by phone at (888) 256-2510.
Why should you contact Block & Leviton?
Block & Leviton is widely regarded as one of the leading securities class action firms in the country. Our attorneys have recovered billions of dollars for defrauded investors and are dedicated to obtaining significant recoveries on behalf of our clients through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, call (888) 256-2510 or email [email protected] with any questions.
This notice may constitute attorney advertising.
CONTACT:
BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (888) 256-2510
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/303646
Source: Block & Leviton LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Philadelphia, Pennsylvania--(Newsfile Corp. - July 2, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of Hub Group, Inc. (NASDAQ: HUBG).
WHAT IS THIS INVESTIGATION ABOUT? The investigation concerns whether certain officers and directors of Hub Group, Inc. breached the fiduciary duties they owed to the company.
If you purchased Hub Group, Inc. (NASDAQ: HUBG), shares prior to April 28, 2023, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit https://grabarlaw.com/the-latest/hubg-shareholder-investigation/, contact Joshua Grabar at [email protected], or call 267-507-6085.
WHY? As alleged in a recently filed securities fraud class action complaint, Hub Group, Inc. (NASDAQ: HUBG), through certain of its executives, violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Hub Group's financial statements prepared for the periods from Q1 2023 to Q4 2024, including annual reports for 2023 and 2024, contained material misstatements caused by the premature and incorrect recognition of certain transactions concerning, among other things, Hub Group's operating revenue, operating income, revenue recognition, effectiveness of internal controls and procedures, and drivers of financial results and growth; and (2) Hub Group's financial statements prepared for the periods from Q1 2025 to Q3 2025 contained material misstatements caused by the understatement of purchased transportation costs and accounts payable concerning, among other things, Hub Group's operating expenses, purchased transportation and warehousing expenses, operating income, effectiveness of internal disclosure controls and procedures, and drivers of financial results and growth.
WHAT CAN YOU DO NOW? If you purchased Hub Group, Inc. (NASDAQ: HUBG), shares prior to April 28, 2023, and still hold shares today, you are encouraged to visit https://grabarlaw.com/the-latest/hubg-shareholder-investigation/, contact Joshua Grabar at [email protected], or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. #HUBG #HubGroup #HUBG
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/303735
Source: Grabar Law Office
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Ameresco, Inc., (NYSE:AMRC), a leading energy infrastructure solutions provider, today announced that it will release its second quarter 2026 financial results after the close of the market on Monday, August 3, 2026. The earnings press release will be available on the “Investor Relations” section of the Company’s website at www.ameresco.com. The Company will host an earnings conference call at 4:30 p.m. EDT the same day.
In conjunction with its earnings conference call and press release, the Company will provide supplemental information concerning the financial results. The supplemental information on a Current Report on Form 8-K will be posted to the “Investor Relations” section of the Company's website.
Those who wish to participate on the day of the call may dial in by calling:
USA & Canada Participants (Toll-Free): 1-888-596-4144
International Participants: 1-646-968-2525
Conference ID: 4849290
A live, listen-only webcast of the conference call will also be available over the Internet. Individuals wishing to listen can access the call through the “Investor Relations” section of the Company’s website at www.ameresco.com. If you are unable to listen to the live call, an archived webcast will be available on the Company’s website for one year.
About Ameresco, Inc.
Founded in 2000, Ameresco, Inc. (NYSE:AMRC) is a leading energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the global energy transition. Our comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. As a trusted full-service partner, Ameresco shows the way by reducing energy use and delivering energy infrastructure solutions to Federal, state and local governments, utilities, data centers, educational and healthcare institutions, housing authorities, and commercial and industrial customers. Headquartered in Framingham, MA, Ameresco has more than 1,500 employees providing local expertise in North America and Europe. For more information, visit www.ameresco.com.
SAN DIEGO, July 02, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving The Ensign Group, Inc. (NASDAQ: ENSG).
If you any have information that could assist in the Ensign investigation or if you are an Ensign investor who suffered a loss and would like to learn more, you may provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
THE COMPANY: Ensign provides skilled nursing, senior living, and rehabilitative services.
THE REVELATION: On June 11, 2026, Muddy Waters Research published a report titled “Ensign: Deceiving the Government at Estimated ~20% of Facilities: Multi-Billion Dollar Potential Liability, Margins and Acquisitions that Cannot be Sustained Without Significant Ongoing Misconduct.” On this news, the price of Ensign stock fell.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Contact:
Robbins Geller Rudman & Dowd LLP
Ken Dolitsky
Michael Albert
655 W. Broadway, Suite 1900, San Diego, CA 92101
800/851-7783 [email protected]
Company secures $10 million line of credit supported by OS Therapies UK tax creditsNew York, New York and Rockville, Maryland--(Newsfile Corp. - July 2, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has appointed Dr. Craig Eagle to the Company's Board of Directors. Dr. Eagle currently serves as the Company's Chief Medical Advisor. The Company also thanks Karim Galzahr for his service to the Board of Directors and will continue as a member of the Company's advisory board.
"Having enjoyed participating in recent U.S., European and U.K. regulatory meetings as we prepare for a late third quarter initiation of the confirmatory Phase 3 study for OST-HER2 in the prevention or delay of recurrence of fully resected, pulmonary metastatic osteosarcoma, we have now reached consensus on the vast majority of key items that pave the way for potential early market authorizations in late 2026," said Dr. Craig Eagle, Chief Medical Advisor and Board Member of OS Therapies. "The progress made on the sustained OST-HER2 overall survival benefit compared with historical control at the 2.5-year timepoint, the unique biomarker signature that predicts that overall survival benefit, as well as critical mass now having been reached in the recruitment into OST-400 all give me confidence as we prepare for U.S. Food & Drug Administration (FDA) Type B Statistical Methods and, thereafter, Type B Pre-BLA meetings to gain full regulatory alignment prior to completing the submission of our ongoing Biologics License Application submission under the Accelerated Approval Program. We are hopeful for decisions on Rolling Review, Regenerative Medicine Advanced Therapy (RMAT) and Breakthrough Therapy designations following the Type B Statistical Methods Meeting."
Dr. Eagle most recently served as Guardant Health's Chief Medical Officer. Prior to joining Guardant Health, Dr. Eagle served as Vice President of Medical Affairs Oncology for Genentech, where he oversaw the medical programs across the oncology portfolio and developed innovative cancer trials and strategies in personalized health care. Prior to Genentech, Dr. Eagle held several leadership roles at Pfizer, including oncology business lead for the United Kingdom and Canada, global lead for Oncology Strategic Alliances and Partnerships, and global head of the Oncology Therapeutic Area Global Medical and Outcomes Group, where he oversaw the U.S. oncology business. Dr. Eagle attended medical school at the University of New South Wales in Sydney, Australia and received his general internist training at Royal North Shore Hospital in Sydney.
"We are thrilled to have Dr. Eagle join our Board of Directors as we look to transition from a development-stage company into a commercial healthcare organization over the next year," said Paul Romness, MPH, Chairman & CEO of OS Therapies.
Concurrent with this announcement, the Company announced a $10 million line of credit (LOC) supported by the Company's wholly-owned subsidiary OS Therapies U.K. tax credits. The Company will receive an initial draw of $1.6 million that primarily supported the second phase OST-HER2 commercial manufacturing following the receipt of global regulatory alignment on the commercial manufacturing pathway for OST-HER2. OS Therapies UK currently has accumulated approximately $5.86 million in pending tax credit refunds and expects to have accumulated a total of $10.2 million through year-end 2026. The Company did not provide security interest in its intellectual property as part of the LOC agreements.
"With a reliable way to monetize the significant R&D investments we made in the fourth quarter of 2025 and the first quarter in the U.K. subsidiary, combined with significantly reduced expenses projected for the third quarter, the Company reiterates that it expects to have sufficient cash and cash resources to provide runway into 2027," said Chris Acevedo, CPA, Chief Financial Officer of OS Therapies.
OST-HER2 has received Orphan Drug Designation (ODD), Fast Track Designation (FTD) and Rare Pediatric Disease Designation (RPDD) from the FDA, and ODD, FTD and ATMP from the EMA. Under the RPDD program, if the Company receives a BLA in the United States, it will become eligible to receive a Priority Review Voucher (PRV) that it intends to sell. The Company is seeking to obtain a BLA under the Accelerated Approval Program for OST-HER2 in osteosarcoma by year-end 2026 in the U.S., in addition to conditional Marketing Authorisation Applications in Europe, the U.K. and Australia.
About OS Therapies
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The Company is the world leader in gene-edited, Listeria-based cancer immunotherapies. OST-HER2, the Company's lead asset, is an immunotherapy leveraging the immune-stimulatory effects of Listeria bacteria to initiate a strong immune response targeting the HER2 protein. OST-HER2 is designed to target two mutated extracellular epitopes and one mutated intracellular epitope of the HER2 oncogene, requiring only one of these three epitopes to be present in a tumor (or micro-metastasis) to trigger the desired immune response. OST-HER2 has received Orphan Drug Designation (ODD), Fast Track Designation (FTD) and Rare Pediatric Disease Designation (RPDD) from the U.S. Food & Drug Administration and has received ODD, FTD and ATMP from the European Medicines Agency.
The Company reported positive data in its Phase 2b clinical trial of OST-HER2 in recurrent, fully resected, lung metastatic osteosarcoma, demonstrating clinically significant benefit in the 12-month event free survival (EFS) primary endpoint of the study and the overall survival (OS) secondary endpoint. The Company is seeking a Biologics License Application (BLA) from the U.S. FDA for OST-HER2 in osteosarcoma in 2026 and, if approved, would become eligible to receive a Priority Review Voucher that it could then sell. The Company also anticipates receiving Conditional Marketing Authorisation Applications from the U.K.'s Medicines and Healthcare products Regulatory Agency and the EMA for OST-HER2 in 2026. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing preclinical efficacy data in various models of breast cancer. OST-HER2 has been conditionally approved by the U.S. Department of Agriculture for the treatment of canines with osteosarcoma. The Company has also completed dosing in a Phase 1 study of OST-504 for castration-resistant prostate cancer.
In addition, OS Therapies is advancing its next-generation Antibody Drug Conjugate (ADC) and Drug Conjugates (DC), known as tunable ADC (tADC), which features tunable, tailored antibody-linker-payload candidates. This platform leverages the Company's proprietary silicone Si-Linker and Conditionally Active Payload (CAP) technology, enabling the delivery of multiple payloads per linker. For more information, please visit www.ostherapies.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements within the meaning of the federal securities laws. These forward-looking statements and terms such as "anticipate," "expect," "intend," "may," "will," "should" or other comparable terms involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding the intent, belief or current expectations of OS Therapies and members of its management, as well as the assumptions on which such statements are based. OS Therapies cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to the potential approval of OST-HER2 by the U.S. FDA and other risks and uncertainties described in "Risk Factors" in the Company's most recent Annual Report on Form 10-K and other subsequent documents the Company files with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by the federal securities laws, OS Therapies specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
July 02, 2026 08:30 ET | Source: Iron Dome Acquisition I Corp.
New York, New York, July 02, 2026 (GLOBE NEWSWIRE) -- Iron Dome Acquisition I Corp. (the “Company”) today announced that, commencing on July 6, 2026, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units.
The Ordinary Shares and Warrants received from the separated Units will trade on The Nasdaq Stock Market (“Nasdaq”) under the symbols “IDAC” and “IDACW”, respectively. Units that are not separated will continue to trade on Nasdaq under the symbol “IDACU”. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Odyssey Transfer and Trust Company, LLC, the Company’s transfer agent, in order to separate the Units into Ordinary Shares and Warrants.
The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination in any business, industry, sector or geographical location, but the Company intends to focus its search on a target business in the cybersecurity, defense tech, AI and data infrastructure industries.
The Units were initially offered by the Company in an underwritten offering. Santander US Capital Markets, LLC acted as sole book-running manager of the offering. Copies of the prospectus relating to the offering may be obtained from Santander US Capital Markets LLC, by email at [email protected], or by telephone at 833-818-1602.
The registration statement relating to the securities became effective on May 14, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward Looking Statements
This press release contains statements that constitute “forward-looking statements.” No assurance can be given that the Company will ultimately complete a business combination transaction. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the U.S. Securities and Exchange Commission (the “SEC”). Copies of these documents are available on the SEC’s website, at www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Contact
Tom Y. Livne
Iron Dome Acquisition I Corp.
Phone: (410) 671-5481
Email: [email protected]
, /PRNewswire/ -- On January 27, 2026, investors in Commvault Systems, Inc. (NASDAQ: CVLT) suffered a devastating 31% stock price collapse after the company delivered disappointing quarterly results.
Since this time, company executives have unloaded millions of dollars in personal stock holdings, as the company faces a federal securities class action alleging it misled investors about its growth prospects.
Hagens Berman is investigating the claims pled in the pending suit and encourages Commvault investors who suffered substantial losses to submit your losses now.
Class Period: Apr. 29, 2025 – Jan. 26, 2026
Lead Plaintiff Deadline: July 17, 2026
Visit: www.hbsslaw.com/investor-fraud/cvlt
Contact the Firm Now: [email protected]
844-916-0895
View our latest video summary of the allegations: youtu.be/YILiBV90q2w
Over $9.4 Million in Recent Executive Stock Sales
According to publicly filed insider trading reports, Commvault's top executives — including its CEO, CFO, and Chief Accounting Officer — have collectively sold over $9.4 million in company shares between February and May 2026:
Sanjay Mirchandani, President & CEO — sold approximately 72,874 shares totaling over $7,015,973 across five separate transactions between February and May 2026. Gary Merrill, Chief Financial Officer — sold approximately 20,474 shares totaling over $2,101,458 across four transactions during the same period. Danielle Nicole Abrahamsen, Chief Accounting Officer — sold approximately 2,951 shares totaling over $305,668 across four transactions during the same period. Commvault Systems, Inc. (CVLT) Securities Class Action:
These insider sales come against the backdrop of a securities class action lawsuit filed on behalf of investors who purchased Commvault securities between April 29, 2025, and January 26, 2026.
The lawsuit alleges Commvault's class period disclosures violated federal securities laws by creating a misleading impression about the company's growth trajectory. Specifically, the complaint alleges that during the Class Period, Commvault repeatedly touted that its "execution has never been better across the business," claimed it would "continue to see hyper-growth within [its] SaaS platform," and promoted its ARR growth and accelerated SaaS target achievement "two quarters earlier than planned."
The truth allegedly emerged on January 27, 2026, when Commvault reported Q3 2026 financial results revealing a significant miss in net new ARR, a reduction in full-year ARR growth guidance, and a dramatic deceleration in SaaS ARR year-over-year growth — plunging from 71% to just 40%. The company revealed for the first time that the composition of its sales activity materially impacted ARR, with volumes increasingly coming from dramatically lower-priced SaaS deals and heavily discounted long-term contracts.
Several analysts reportedly characterized the results as a "mess" and questioned Commvault's ability to execute, promptly downgrading the stock.
HBSS Investigation
"We're investigating whether Commvault misled investors regarding its ARR growth by masking the impact of lower-priced SaaS deals and heavy discounting, as the complaint alleges," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.
If you invested in Commvault and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now.
If you'd like more information and answers to frequently asked questions about the Commvault case and the firm's investigation, read more »
Whistleblowers: Persons with non-public information regarding Commvault should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
Constellation Brands Inc. (NYSE:STZ) posted better-than-expected first-quarter results after Tuesday’s closing bell.
Constellation Brands reported quarterly earnings of $3.43 per share, which beat the consensus estimate of $3.21 by 6.85%, according to Benzinga Pro data. Quarterly revenue clocked in at $2.43 billion, which beat the Street estimate of $2.39 billion.
"I see significant runway to continue growing our leading brands with an even greater emphasis on understanding consumer occasions and relevance — increasingly looking at our business through the lens of when, where and why consumers are choosing our brands," said CEO Nicholas Fink.
Constellation Brands affirmed its fiscal year adjusted EPS guidance of $11.20 to $11.90, versus the $11.75 analyst estimate.
Constellation shares rose 0.1% to $136.95 in pre-market trading.
These analysts made changes to their price targets on Constellation following earnings announcement.
Barclays analyst Lauren Lieberman maintained the stock with an Equal-Weight rating and lowered the price target from $170 to $139. Morgan Stanley analyst Dara Mohsenian maintained the stock with an Equal-Weight rating and lowered the price target from $183 to $158. Needham analyst Gerald Pascarelli reiterated Constellation Brands with a Buy and maintained a $185 price target. Considering buying STZ stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
The Dow just closed out its best first half since 2021, up 8.7% year-to-date, yet Wednesday’s open felt like a nervous glance at the door. CNBC’s Dominic Chu kicked off July with mixed earnings, one big M&A shrug, and a jobs report that gave the bulls something to chew on.
Chu flagged the labor data. “ADP this morning reported that 98,000 jobs were added last month, that was below the consensus for economists of 110,000,” A miss of that size lands on top of a labor market quietly softening for a year. The Bureau of Labor Statistics has unemployment at 4.3% for three straight months, up from 3.9% in May 2024.
The Sahm Rule currently reads 0.10, well below the 0.50 recession trigger, though it spiked to 0.43 in November 2025 before easing back. Consumer sentiment tells a scarier story. The University of Michigan index just printed 44.8, down 5.0 points month-over-month and closing in on recessionary territory below 60. Kalshi traders are pricing a 21% probability that rates stay above 4.25% by the January 27, 2027 FOMC meeting, which means the crowd expects cuts.
Software’s redemption tour with Salesforce and ServiceNow “Software giants Salesforce and ServiceNow are both up around 4%… after Guggenheim upgraded both stocks to a buy rating,” Chu noted, citing attractive valuations and the argument that both companies can weather AI disruption. Salesforce (NYSE:CRM | CRM Price Prediction) needed the boost. The stock is down 35% year-to-date at $163, a brutal contrast to the underlying business, which delivered Q1 FY27 EPS of $3.88 versus the $3.13 consensus and Agentforce ARR of $1.2 billion, up 205% year-over-year. Marc Benioff announced a $25 billion accelerated share repurchase, which is management speak for “we think this is silly.”
ServiceNow (NYSE:NOW) sits in the same penalty box, down 28% YTD despite Q4 revenue growing 20.7% year-over-year to $3.57 billion. Bill McDermott bought Moveworks, agreed to buy Armis and Veza, and keeps insisting agentic AI is a tailwind. The Q4 filing guides FY26 subscription revenue to $15.53 billion to $15.57 billion. Guggenheim is essentially saying the fundamentals have decoupled from the stock price, and the share price has to catch up.
Nike beats, China bleeds “Nike shares are down 1% after the apparel company reported a 12% sales decline in the key China market,” Chu said. Technically, Nike (NYSE:NKE) crushed the number, posting EPS of $0.72 versus the $0.1273 consensus, but that beat came almost entirely from a $986 million one-time IEEPA tariff-recovery benefit following the Supreme Court ruling.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Salesforce didn't make the cut. Grab the names FREE today.
Strip that out and the picture is uglier. Revenue slipped 1.1% year-over-year, NIKE Direct fell 7%, and Converse dropped 32%. Elliott Hill called fiscal 2026 a foundation-strengthening year in the earnings release. Shares are down 73% over five years.
Constellation pops, Kroger sags on the Giant Eagle deal Constellation Brands (NYSE:STZ) posted Q1 comparable EPS of $3.43 beating the $3.21 estimate and organic net sales growing 3%. Pacifico depletions rose 21% and Victoria climbed 14%, offsetting softness in Modelo Especial and Corona Extra. Full-year comparable EPS guide of $11.20 to $11.90 was affirmed.
Kroger (NYSE:KR) went down after announcing it will acquire Giant Eagle for roughly $1.7 billion. New CEO Greg Foran is trying to reset the story after the Albertsons collapse. Q1 adjusted EPS of $1.58 came in a penny light of the $1.59 estimate snapped a four-quarter beat streak. Shares are down 10.7% YTD.
What to watch as H2 begins Wage growth is still hot at $37.53 in May 2026 versus $36.28 a year prior, hiring is cooling, sentiment is at recession-adjacent levels, and the Dow just had its best six months in five years. Keep an eye on Friday’s official BLS report. If it confirms the ADP softness, the Fed conversation shifts fast, and the software rally may finally get the multiple expansion the fundamentals have been begging for.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Salesforce didn't make the cut. Grab the names FREE today.
TULSA, Okla.--(BUSINESS WIRE)--Alliance Resource Partners, L.P. (NASDAQ: ARLP) ("ARLP") today announced that it has completed its previously announced acquisition of certain general partner and limited partner interests in AllDale Minerals III, LP and AllDale Minerals IV, LP for approximately $206.2 million, subject to customary post-closing adjustments.
ARLP funded the acquisition using a combination of cash on hand, borrowings under its revolving credit facility, and a new $150.0 million term loan at its wholly owned subsidiary Alliance Minerals, LLC.
Following the acquisition, ARLP now controls approximately 115,680 net royalty acres within its Oil & Gas Royalties segment, including over 44,770 net royalty acres in the Permian Basin. ARLP expects to provide additional commentary regarding the acquisition during its next quarterly earnings conference call.
About Alliance Resource Partners, L.P.
ARLP is a diversified natural resource company that is currently the second largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as a reliable energy partner for the future by pursuing opportunities that support the growth and development of energy-related technologies and infrastructure.
News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via email at [email protected].
The statements and projections used throughout this release are based on current expectations. These statements and projections are forward-looking, and actual results may differ materially. These projections do not include the potential impact of any mergers, acquisitions or other business combinations that may occur after the date of this release. We have included more information below regarding business risks that could affect our results.
FORWARD-LOOKING STATEMENTS: With the exception of historical matters, any matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from projected results. Those forward-looking statements include expectations with respect to our future financial and operational performance, coal and oil & gas consumption and expected future prices, our ability to increase or maintain unitholder distributions in future quarters, business plans and potential growth with respect to our energy and infrastructure investments, optimizing cash flows, reducing operating and capital expenditures, infrastructure projects at our existing properties, growth in domestic electricity demand, preserving liquidity and maintaining financial flexibility, and our future repurchases of units. These risks to our ability to achieve these outcomes include, but are not limited to, the following: decline in the coal industry’s share of electricity generation, including as a result of environmental concerns related to coal mining and combustion, the cost and perceived benefits of other sources of electricity and fuels, such as oil & gas, nuclear energy, and renewable fuels and the retirement of coal-fired power plants in the U.S.; our ability to provide fuel for growth in domestic energy demand, should it materialize; changes in macroeconomic and market conditions and market volatility, and the impact of such changes and volatility on our financial position; changes in global economic and geo-political conditions or changes in industries in which our customers operate; changes in commodity prices, demand and availability which could affect our operating results and cash flows; impacts of geopolitical events, including the conflicts in Ukraine and in the Middle East; actions of the major oil-producing countries with respect to oil production volumes and prices and the direct and indirect impacts over the near and long term on oil & gas exploration and production operations at the properties in which we hold mineral interests; changes in competition in domestic and international coal markets and our ability to respond to such changes; potential shut-ins of production by the operators of the properties in which we hold oil & gas mineral interests due to low commodity prices or the lack of downstream demand or storage capacity; risks associated with the expansion of and investments into the infrastructure of our operations and properties, including the timing of such investments coming online; our ability to identify and complete acquisitions and to successfully integrate such acquisitions into our business and achieve the anticipated benefits therefrom; our ability to identify and invest in new energy and infrastructure ventures; the success of our development and growth plans for our wholly owned subsidiary, Matrix Design Group, LLC, and our investments in emerging and other infrastructure and technology companies; dependence on significant customer contracts, and failure of customers to renew existing contracts upon expiration; adjustments made in price, volume, or terms to existing coal supply agreements; the effects of and changes in trade, monetary and fiscal policies and laws, and the results of central bank policy actions including interest rates, bank failures, and associated liquidity risks; the effects of and changes in taxes or tariffs and other trade measures adopted or threatened by the United States and foreign governments, including the imposition of or increase in tariffs on steel and/or other raw materials; legislation, regulations, and court decisions and interpretations thereof, both domestic and foreign, including those relating to the environment and the release of greenhouse gases, such as state legislation seeking to impose liability on a wide range of energy companies under greenhouse gas “superfund” laws, mining, miner health and safety, hydraulic fracturing, and health care; deregulation of the electric utility industry or the effects of any adverse change in the coal industry, electric utility industry, or general economic conditions; investors’ and other stakeholders’ attention to sustainability matters; liquidity constraints, including those resulting from any future unavailability of financing; customer bankruptcies, cancellations or breaches to existing contracts, or other failures to perform; customer delays, failure to take coal under contracts or defaults in making payments; our productivity levels and margins earned on our coal sales; disruptions to oil & gas exploration and production operations at the properties in which we hold mineral interests; changes in equipment, raw material, service or labor costs or availability, including due to inflationary pressures or tariffs; changes in our ability to recruit, hire and maintain labor; our ability to maintain satisfactory relations with our employees; increases in labor costs, including increases in the costs of health insurance, adverse changes in work rules, or cash payments or projections associated with workers’ compensation claims; increases in transportation costs and risk of transportation delays or interruptions; operational interruptions due to geologic, permitting, labor, weather, supply chain shortage of equipment or mine supplies, or other factors; risks associated with major mine-related accidents, mine fires, mine floods or other interruptions; results of litigation, including claims not yet asserted; foreign currency fluctuations that could adversely affect the competitiveness of our coal abroad; difficulty maintaining our surety bonds for mine reclamation as well as workers’ compensation and black lung benefits; difficulty in making accurate assumptions and projections regarding post-mine reclamation as well as pension, black lung benefits, and other post-retirement benefit liabilities; uncertainties in estimating and replacing our coal mineral reserves and resources; uncertainties in estimating and replacing our oil & gas reserves; uncertainties in the amount of oil & gas production due to the level of drilling and completion activity by the operators of our oil & gas properties; the impact of current and potential changes to federal or state tax rules and regulations, including a loss or reduction of benefits from certain tax deductions and credits; difficulty obtaining commercial property insurance, and risks associated with our participation in the commercial insurance property program; evolving cybersecurity risks, such as those involving unauthorized access, denial-of-service attacks, malicious software, data privacy breaches by employees, insiders or others with authorized access, cyber or phishing attacks, ransomware, malware, social engineering, physical breaches, or other actions; and difficulty in making accurate assumptions and projections regarding future revenues and costs associated with equity investments in companies we do not control.
Additional information concerning these, and other factors can be found in ARLP’s public periodic filings with the SEC, including ARLP’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 26, 2026, and ARLP’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 8, 2026. Except as required by applicable securities laws, ARLP does not intend to update its forward-looking statements.
MANCHESTER, N.H., July 02, 2026 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today introduced the A81415, the industry's first ASIL-D-certified Power Management IC (PMIC) to integrate a wheel-speed sensor interface. The new device provides electromechanical braking (EMB) designers with a substantially simplified, single-chip power and sensing foundation for next-generation brake-by-wire systems.
Brake-by-wire is fast becoming a foundational chassis technology in software-defined vehicles. But while much of the automotive industry’s design focus is on centralizing compute platforms, the physical act of stopping a vehicle happens at the wheel. This location places a hard set of demands on corner module electronics to deliver fail-operational power and accurate wheel-speed data in tight spaces that are vibration-prone and thermally stressed – all while meeting the highest functional safety bar.
Today, designers are forced to stitch together generic safety PMICs, separate wheel-speed decoders, and clusters of discrete power components. In addition to adding cost and consuming valuable board space, that approach multiplies potential failure points at the exact location where reliability matters most.
One Device, Built for the Task
With an on-chip wheel-speed sensor interface (WSSI), the A81415 safety PMIC decodes standard 2-level, 2-level Pulse Width Modulation (PWM), and 3-level AK protocols (standard and high-resolution) without complicated analog circuitry or a separate decoder IC. By incorporating a fully integrated buck-boost pre-regulator, five Low-Dropout (LDO) regulators, and a single-inductor architecture that requires no external switches or diodes, the A81415 eliminates up to nine external components and unlocks up to $4 in semiconductor bill-of-materials (BOM) savings per vehicle, delivering meaningful cost advantages at OEM production scale This unprecedented level of integration opens up more than 50% of usable board space to provide the brake caliper with critical design headroom.
Because the physical layer of the wheel-speed data is handled internally by the PMIC and the decoded data is shared over a Serial Peripheral Interface (SPI), the A81415 trims latency in the safety-critical loop and frees MCU bandwidth for faster braking response. Low-noise power rails are explicitly tuned to power Allegro's XtremeSense™ TMR angle sensors and ensure the entire commutation and clamping-force signal chain is optimized as one coherent, high-resolution system from wheel to caliper.
The 12V-to-48V Fast Track for Corner Modules
True brake-by-wire operation requires components capable of surviving the harshest electrical environments. Built on Allegro's proprietary automotive grade-0 process and paired with the APM81815 pre-regulator and 48V gate drivers, the A81415 forms a complete, fail-operational chipset. This modular approach provides Tier 1 suppliers with a fast track to migrate proven 12V braking architectures directly to next generation 48V corner modules without redesign or bulky external transient protection.
“Intelligent chassis systems demand that sensing and power electronics at the wheel act as one,” said Peter Wells, Business Line Director, High Performance Power at Allegro MicroSystems. “Allegro combined our wheel-speed sensing leadership and high-reliability power management expertise into our new PMIC to give our customers a simpler, safer and highly scalable foundation for modern vehicle brake-by-wire.”
A81415 Features and Benefits:
Integrated wheel-speed sensing: On-chip WSSI decodes 2-level, PWM, AK, and high-definition protocols, eliminating a separate decoder IC.Cost and space savings: Eliminates up to nine external components, saving up to $4.00 in semiconductor BOM per vehicle and over 50% of PCB area.ASIL-D and AEC-Q100 qualified: Dual watchdogs and built-in fault handling meet the highest safety standards without requiring external protection circuitry.12V-to-48V scalable: Operates natively in 12V systems with a simple upgrade path to 48V corner modules when paired with the APM81815 pre-regulator. Availability
Attendees of electronica Shanghai are invited to visit the Allegro MicroSystems booth at N5.300 to learn more. For more information, samples, or evaluation support, visit www.allegromicro.com/a81415.
About Allegro MicroSystems
Allegro MicroSystems, Inc. is leveraging more than three decades of expertise in magnetic sensing and power ICs to propel electrification, automation, AI data center, and robotics forward with solutions that enhance efficiency, performance and sustainability. Allegro’s commitment to quality drives transformation across industries, reinforcing our status as a pioneer in “automotive-grade” technology and a partner in our customers' success. For additional information, visit allegromicro.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release, including statements regarding the anticipated performance, customer benefits, cost savings, and market opportunities associated with our A81415 PMIC, and the adoption of brake-by-wire and 48V automotive architectures, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
In some cases, you can identify forward-looking statements by terms such as “will,” “expect,” “anticipate,” “plan,” “project,” “believe,” “estimate,” “potential,” or other similar expressions. No forward-looking statement is a guarantee of future performance, and you should avoid placing undue reliance on these statements.
Forward-looking statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: our ability to successfully develop and commercialize new products; customer adoption rates of emerging automotive technologies; the timing and success of customer design wins; our ability to compete effectively; and other risk factors identified in our Annual Report on Form 10-K for the year ended March 27, 2026, as updated by our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. All forward-looking statements speak only as of the date of this press release, and except as required by law, we assume no obligation to update them.
Media Contact:
Andrew MacLellan
Corporate Communications
(617) 633-4909
[email protected] Allegro Contact:
Ram Sathappan
Vice President of Global Marketing and Applications
[email protected] A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/12550647-57b4-4e54-9067-d30578336d29
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INMODE LTD. (INMD), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@.
Bloom Energy (BE 4.51%) is perfectly positioned for the artificial intelligence spending boom underway today. In fact, the company's backlog for hydrogen fuel cells at the start of 2026 rose over 2.5x year over year, hitting $6 billion. But the real story here is the other $14 billion of the total $20 billion backlog, which is related to services.
What does Bloom Energy do? Bloom Energy makes hydrogen fuel cells. They are built in a factory and can be delivered wherever they are needed to provide on-site power. The power generated doesn't produce greenhouse gases, either, so it is clean energy. The company has been building its business and improving its technology for many years, but the current environment is almost the perfect setting for success.
Image source: Getty Images.
Spending on artificial intelligence (AI) has exploded. But AI is just a fancy computer program, so it can't operate without electricity. Electric utilities are working to supply the power needed, but building electric infrastructure takes time. And there has been pushback from consumers and regulators around the impact that AI demand is having on power prices.
Bloom Energy's on-site power lets AI companies sidestep the grid. And Bloom Energy can usually deliver power cells more quickly than a utility can provide a grid connection, speeding up the construction of new AI data centers. No wonder the company started 2026 with a $6 billion backlog of fuel cell orders, up 2.5x year over year.
Bloom Energy's real flywheel is services That said, the company's full backlog is around $20 billion. The other $14 billion relates to the service contracts that accompany the sale of a fuel cell. These are long-term contracts that provide annuity-like income streams. Each new product sale builds the company's long-term service momentum. Although Bloom Energy is really just a start-up that has yet to turn sustainably profitable, that could change very soon.
Today's Change
(
-4.51
%) $
-13.65
Current Price
$
289.05
The only problem with Bloom Energy's story is that it is so well-known on Wall Street. The stock is up over 1,000% over the past year. Without sustainable earnings, the price-to-earnings ratio isn't meaningful. However, the price-to-sales ratio is shockingly high at 29x, compared to a five-year average of 3.1x. The forward P/E ratio is 134x. That is high and shows just how much investors are expecting from the company.
Bloom Energy is probably best left on your wishlist for now, given the stock's rapid ascent. However, if the AI bubble on Wall Street bursts, Bloom Energy's massive service backlog could make it worth a second look.
Bloom Energy delivered exceptional first-quarter results, with explosive revenue growth, record profitability, expanding margins, and strong free cash flow, validating its accelerating business transformation. Demand from hyperscale data centers continues strengthening, as customers increasingly seek Bloom's fuel-cell technology to secure reliable power without waiting for traditional grid expansion. The expanded Brookfield partnership significantly improves long-term revenue visibility while reducing financing constraints for customers deploying Bloom's power infrastructure across large AI projects globally.
ATLANTA--(BUSINESS WIRE)--Ameris Bancorp (NYSE: ABCB) (the “Company”) announced today that it intends to release its second quarter 2026 financial results in a press release after the market closes on Thursday, July 23, 2026. H. Palmer Proctor, Jr., Chief Executive Officer, Nicole S. Stokes, Chief Financial Officer, and Douglas D. Strange, Chief Credit Officer, will host a teleconference at 9:00 a.m. Eastern time on Friday, July 24, 2026 to discuss the Company's results and answer appropriate q.
MINNEAPOLIS--(BUSINESS WIRE)--U.S. Bancorp (NYSE: USB) will release its second quarter 2026 earnings results before the market opens on Thursday, July 16, 2026. At 7 a.m. CT, Chairman and Chief Executive Officer Gunjan Kedia and Vice Chair and Chief Financial Officer John Stern will host a conference call to review the financial results. The live conference call will be available online or by telephone.
Via internet:
To access the webcast and presentation, visit the U.S. Bancorp website at usbank.com and click on “About Us”, “Investor Relations” and choose “Webcasts & Presentations” from the “News & events” dropdown menu.
Via telephone:
To access the conference call from locations within the United States and Canada, please dial 888-210-4659. Participants calling from outside the United States and Canada, please dial 646-960-0383. The access code for all participants is 7269933.
Replay info:
For those unable to participate during the live call, a replay will be available beginning at approximately 10 a.m. CT on Thursday, July 16, 2026. To access the replay, please visit the U.S. Bancorp website at usbank.com and click on “About Us”, “Investor Relations” and “Webcasts & Presentations.”
About U.S. Bancorp
Headquartered in Minneapolis, U.S. Bancorp is the parent company of U.S. Bank National Association, the fifth-largest commercial bank in the United States. The company’s three major business lines serve 15 million clients globally, and its team of nearly 70,000 people invest their hearts and minds to power human potential every day. Ranked 110th on the Fortune 500, U.S. Bancorp is deeply respected for its culture and long-term stewardship and admired for its diversified business mix and product capabilities.
July 02, 2026 09:00 ET | Source: Kish Bancorp, Inc.
STATE COLLEGE, Pa., July 02, 2026 (GLOBE NEWSWIRE) -- Kish Bancorp, Inc. (OTCQX: KISB) (“Kish” or the “Company”), parent company of Kish Bank, today announced that on July 1, 2026, its Board of Directors increased its regular quarterly cash dividend by $0.04, or 10%, to $0.44 per share. The dividend will be payable July 31, 2026, to shareholders of record on July 15, 2026.
“Our sustained profitability has enabled us to raise the cash dividend for the eleventh consecutive year, while continuing to retain a significant portion of our earnings to support our growth strategies,” said Gregory T. Hayes, President and Chief Executive Officer. “The increased dividend reflects the Board’s confidence in the strength of our business model and reaffirms our unwavering commitment to building sustained performance for our shareholders.”
Kish Bancorp has paid uninterrupted dividends since the formation of the holding company in 1987, and previously as Kishacoquillas Valley National Bank.
About Kish Bancorp, Inc.
Kish Bancorp, Inc. is a diversified financial services corporation headquartered in Belleville, PA, with executive offices in State College, PA and an Innovation Center in Reedsville, PA. Kish Bank, a subsidiary of Kish Bancorp, Inc., operates 20 locations serving Centre, Mifflin, Huntingdon, Blair, and Juniata counties in Pennsylvania, as well as northeastern Ohio. In addition to Kish Bank, other business units include: Kish Insurance, an independent property and casualty insurance agency; Kish Financial Solutions, which offers trust, fiduciary, and wealth management advisory services; Kish Benefits Consulting, which provides employee benefits consulting services; and Kish Travel, a full-service travel agency. KISB is the OTCQX stock ticker symbol for Kish Bancorp, Inc. For additional information, please visit ir.kishbancorp.com or otcmarkets.com/stock/KISB.
Axsome Therapeutics (AXSM 1.68%) has been going through a particularly significant growth phase in recent years, launching drugs for central nervous system (CNS) conditions and pushing several candidates through late-stage clinical trials. Investors have recognized the company's potential and piled into the stock -- it's climbed more than 220% over the past three years.
And considering these product launches are pretty recent, and any pipeline success could produce new revenue drivers, it's fair to say this biopharma company is in the early days of its growth story. Considering this, is Axsome stock a millionaire maker? Let's take a look at what the numbers say.
Image source: Getty Images.
Three approved drugs First, though, let's take a close look at Axsome's story as a commercial-stage company. Axsome specializes in the treatment of CNS disorders, a market that spans Alzheimer's disease, major depressive disorder, narcolepsy, fibromyalgia, and other conditions. So Axsome's capabilities open the door to many markets that could support growth over time. The company sells Auvelity for agitation linked to Alzheimer's disease, and the drug is also approved for depression. Axsome's other products are Sunosi for daytime sleepiness associated with sleep apnea or narcolepsy, and Symbravo for migraine relief.
The two most recent approvals include the Alzheimer's indication for Auvelity in April of this year and the approval of Symbravo in January of last year. So the company is in the early stages of growth in those areas -- and the potential of Axsome's drugs was evident in the latest earnings report.
Today's Change
(
-1.68
%) $
-4.11
Current Price
$
240.66
Double-digit product revenue growth Auvelity product revenue soared 59% in the quarter to $153 million, and Sunosi revenue climbed 34% to $33 million. Symbravo only launched early last year, so it doesn't have a year-over-year comparison figure -- but the company offered clues that give investors reason to be optimistic about the drug's potential. Doctors wrote about 17,000 prescriptions for the migraine drug in the first quarter, and based on the drug's growth, Axsome is increasing its Symbravo sales force.
It's also important to note that the company may still progress on payer coverage for Symbravo, which should trigger additional growth. Right now, coverage is at 57% compared to more than 80% for the company's other drugs.
Another potentially big growth driver for Axsome is the Alzheimer's indication. Auvelity was just made available to these patients in June, with a sales force of more than 600 to bring the treatment to the attention of doctors, from primary care physicians to neurologists and geriatric specialists.
Another potential launch on the horizon Meanwhile, Axsome has submitted AXS-12 for narcolepsy to regulators for review, so another product launch may be on the horizon. And the company has solriamfetol in phase three trials for four indications: attention deficit hyperactivity disorder, major depressive disorder, binge eating disorder, and shift work disorder. Finally, AXS-14 for fibromyalgia is also in a phase 3 trial. So the company's late-stage pipeline is almost bursting at the seams, which could lead to explosive growth in the coming years if all goes smoothly.
It's clear that Axsome is a young biopharmaceutical company that's on the rise, due to recently launched drugs and candidates that are nearing the finish line. Now let's get back to our question: Could this stock make you a millionaire?
Axsome stock has climbed quite a bit in recent times, but it still could have plenty of room to run as the era of revenue growth unfolds. The company has $305 million in cash and says this position will help it fund operations "into cash flow positivity." So we really are at the start of the Axsome story.
Still, a look at the numbers shows us just how difficult it is to reach $1 million by investing in one stock. For example, if you invested $1,000 in Axsome stock and it climbed 500%, you would have $6,000. That would leave Axsome stock trading at more than $1,400 -- and at a trillion-dollar market value. That's very unlikely.
But this doesn't mean you should avoid Axsome stock. The best way to reach $1 million through investing is to buy shares of many quality companies -- and Axsome would make an excellent part of the group -- and hold on for the long term.
RESTON, Va.--(BUSINESS WIRE)-- #LimitlessPotential--CACI International Inc (NYSE: CACI) announced today that Tom Kirkland has rejoined the company as Executive Vice President of Electronic Warfare. In this role, Kirkland will lead CACI's Electronic Warfare line of business and serve on the company's executive leadership team. Kirkland brings deep defense technology, customer engagement, and business leadership experience across all domains and mission-focused technology businesses. He rejoins CACI as the company con.
American States Water exemplifies reliability, boasting a 71-year dividend growth streak and consistent operational excellence. AWR delivered solid Q1 2026 results, with 14.3% revenue growth and 8.6% EPS growth, driven by rate increases and infrastructure investments. Shares are fairly valued. AWR is a wonderful company at a fair price.
PLANO, Texas, July 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), announced today that it will webcast its conference call to discuss financial results and business highlights for the second quarter ended July 3, 2026, on Thursday, Aug. 6, 2026, at 8 a.m. CT (9 a.m. ET). Other forward-looking and material information may also be discussed during the call.
The company will issue a news release announcing its financial results for the second quarter on Aug. 6, 2026 prior to the conference call.
Conference call details:
Date: Thursday, Aug. 6, 2026Time: 8 a.m. CT (9 a.m. ET)Domestic dial-in number: 800-715-9871International dial-in number: 646-307-1963Conference ID: 3120125Webcast Registration: ITGR Q2 2026 Earnings Call An audio replay will be available for seven days and can be accessed by dialing 800-770-2030 or 609- 800-9909 and using Conference ID 3120125. The conference call will also be available live and via archived replay on the Investor Relations section of the Integer website at: investor.integer.net.
From time to time, Integer posts information that may be of interest to investors on its website. To automatically receive Integer financial news by email, please visit investor.integer.net and subscribe to email alerts.
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.
Contacts
Media Relations:
Misty Tippen [email protected]
469-536-6702
Energy Transfer remains a Strong Buy, driven by robust 12.5% adj. EBITDA growth targets and a compelling income profile. ET trades at a 26.2% EV/EBITDA discount to peers despite sector-leading growth and resilient segment performance. Strategic investments, export terminal expansions, and SUN's acquisition-driven EBITDA surge reinforce ET's forward growth trajectory.
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center
My Stock Lists
Email Preferences
Help & Support
Sign Out
Search stocks or keywords
Sections
My IBD
MARKET TREND
STOCK LISTS
STOCK RESEARCH
NEWSECONOMY
VIDEOS & PODCASTS
HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live
Recently Searched
Morgan Stanley, Dell, Other Rising Leaders Join IBD Top Stock Screens
Signal Or Noise? Deciphering The Fed's New Direction.
Stock Market Skids As Trump Makes This Trade Call; Jobs Report Due Data center contractor Comfort Systems USA (FIX) has a three-year earnings-per-share growth rate of 78%, according to IBD Stock Checkup. That may well continue as the provider of building infrastructures expects strong growth not only in data centers, but chip manufacturing and energy storage as well, according to a Feb. 20 presentation to investors. Comfort Systems is one of the…
I have been steadily adding to my Energy Transfer (ET 0.50%) position this year. I've purchased units of the master limited partnership (MLP) three times already this year. It's one of my favorite energy investments for generating passive income. I also like that the midstream company has strong growth visibility as it builds out its natural gas infrastructure to support growing power demand from AI data centers.
However, as much as I like investing in the MLP, Brookfield Infrastructure (BIPC 0.75%)(BIP 1.34%) has surpassed it as my favorite energy stock to buy right now. Here's why it's the first one I plan to buy in July.
Image source: Getty Images.
A more compelling value proposition this month Energy Transfer is having a strong year. Units of the MLP are already up more than 15%, nearly doubling the S&P 500's 8% return. That surge has driven down its distribution yield to 7%. While that's still a very attractive level compared to the S&P 500's 1.1% yield, it's not as high as it was earlier this year.
Brookfield Infrastructure, on the other hand, has trailed both the S&P 500 and Energy Transfer by declining more than 15% on the year. That sell-off has driven down its dividend yield to 4.7%. That's a very attractive level for such a high-quality income stream. Brookfield has increased its dividend for 17 straight years (every year since its inception), growing it at a 9% compound annual rate. The company expects to deliver 5% to 9% annual dividend growth going forward, much faster than the 3% to 4% annual distribution growth rate Energy Transfer expects.
Today's Change
(
-0.75
%) $
-0.29
Current Price
$
38.21
Faster, broader AI-fueled growth Shares of Brookfield Infrastructure have sold off this year even though its growth rate is accelerating. The company's funds from operations (FFO) per share grew 10% in the first quarter, up from the 6% growth rate it delivered last year. Notable drivers included its data segment (up 46%) and its energy midstream segment (up 12%).
Brookfield Infrastructure expects to deliver more than 10% annual FFO per share growth going forward. It anticipates delivering 6% to 9% annual organic growth, driven by inflation-indexed rate increases, volume growth as the global economy expands, and growth capital projects. Brookfield currently has over $9 billion of growth capital projects in its backlog across its utilities, transport, midstream, and data infrastructure segments. Its expertise in energy is leading Brookfield to invest directly in developing data centers. It's also investing in deploying advanced fuel cells at data centers under long-term contracts with the operating tenants.
Additionally, Brookfield expects to continue making value-enhancing acquisitions. The company has secured about $1.5 billion of new investments over the past year, including an interest in a leading U.S. refined products pipeline system, a South Korean industrial gas business, and a natural gas infrastructure business in New Zealand. These and future acquisitions should help push its growth rate above 10% annually.
Overall, Brookfield has a much more diversified growth profile compared to Energy Transfer, with multiple AI-related catalysts. While Energy Transfer is building new gas pipelines to support AI-driven power demand, Brookfield is investing directly in powered AI data centers. It's also investing in natural gas pipelines and utility projects to support rising power demand. Additionally, it's investing in other AI infrastructure solutions, including an industrial gas business in South Korea that supports semiconductor manufacturers, and recently launched an exclusive industrial equipment leasing platform for data centers.
A better opportunity this month Energy Transfer remains one of my favorite income investments from the energy sector. However, Brookfield Infrastructure is a more compelling investment opportunity this month, given its 15% year-to-date decline in share price. That boosted its yield and total return potential, which is why I plan to make it the first energy stock I buy in July.
, /PRNewswire/ -- Hagerty, Inc. (NYSE: HGTY), a business that makes it easier and more enjoyable to be a driving enthusiast through insurance, buying and selling platforms, publishing and events, today announced that it has entered into a definitive agreement to acquire Bennetts, the United Kingdom's #2 specialty motorcycle insurance broker, from Lucida Group for £34 million ($43 million USD). The transaction is expected to be immediately accretive, and close during the third quarter of 2026, subject to regulatory approval. The acquisition increases Hagerty's international scale, augmenting the ongoing investment into Hagerty's Broad Arrow business outside of the United States.
Hagerty Agrees to Acquire Bennetts to Become #2 Specialty Motorcycle Insurance Broker in the United Kingdom Founded more than 90 years ago, Bennetts brings 15% UK motorcycle insurance market share and a 65 Net Promoter Score through a member-centric approach similar to Hagerty's model in the enthusiast car space.
"Bennetts is a brand built the same way Hagerty was built – by genuine enthusiasts, for genuine enthusiasts," said McKeel Hagerty, Chief Executive Officer and Chairman of Hagerty. "Their 100,000 community members from Bennetts' 'Bike Social' platform, decades of trust in the UK motorcycle market and disciplined, low-frequency book make this a natural extension of everything we stand for as we look to seed our international growth in a deliberate way."
Mark Roper, Hagerty's UK Managing Director added, "We are excited to welcome the Bennetts team into the Hagerty family. Bennetts has built something special — a brand riders trust, a community they love and a business with momentum. Our commitment is simple: keep what makes Bennetts great, and bring the best of Hagerty alongside it, building something stronger than either of us could on our own."
Tripling Hagerty's UK Footprint
The acquisition is also expected to triple Hagerty's UK revenue to approximately £25 million, and to be financially accretive from day one, even before the realisation of identified synergies.
This acquisition builds on the international momentum Hagerty has established through Broad Arrow Auctions, which has expanded its European presence over the past year. Together, both brands can create a more integrated enthusiast platform in the United Kingdom – combining specialty insurance, live and digital auctions and community engagement across both motorcycles and enthusiast cars with meaningful cross-sell opportunities.
Bennetts' book comprises 92% enthusiast riders and has a risk profile that closely mirrors Hagerty's enthusiast car insurance portfolio. Bennetts' 4.7/5.0 Trustpilot rating, 250,000 YouTube subscribers, and 41 million annual social media interactions reflects an exceptional level of authentic community engagement.
Editors Notes.
About Bennetts
Established in 1930, Bennetts is one of the UK's leading motorcycle insurance brokers, offering Defaqto 5 Star Rated coverage across classic and modern bikes. With a panel of trusted insurers and a comprehensive suite of policy features, Bennetts combines competitive pricing with an exceptional customer experience. Riders who insure directly with Bennetts receive free BikeSocial membership, an exclusive platform offering discounts, experiences, and a thriving enthusiast community.
About Hagerty, Inc. (NYSE: HGTY)
Hagerty is a company built by drivers for drivers, protecting 2.9 million vehicles in the United States, Canada and the UK. We make it easier and more enjoyable for enthusiasts to drive and celebrate the machines they love through innovative insurance products, live and digital auctions, engaging media and events, as well as the Hagerty Drivers Club, the world's largest community of car lovers.
Forward-Looking Statements - All statements contained in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected timing and completion of the acquisition and its anticipated strategic, operational and financial impact. Forward-looking statements are based on Hagerty's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including the risk (i) that the acquisition may not be completed on the expected terms or timeline, or at all; (ii) that the closing conditions may not be satisfied; (iii) that the anticipated benefits of the acquisition may not be realized, including earnings enhancements and synergies; (iv) that Hagerty may be unable to successfully integrate Bennetts with its U.K. business or that integration costs may exceed expectations; (v) of potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement of the acquisition; (vi) that Hagerty may not have identified certain risks relating to Bennetts' business or underestimated the severity or probability of certain risks relating to Bennetts' business; and (vii) other risks described in Hagerty's filings with the U.S. Securities and Exchange Commission. Hagerty undertakes no obligation to update or revise any forward-looking statements, except as required by law.
San Diego, California--(Newsfile Corp. - July 2, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Peabody Energy Corporation (NYSE: BTU) common stock between October 14, 2024 and May 4, 2026, both dates inclusive (the "Class Period"), have until August 24, 2026 to seek appointment as lead plaintiff of the Peabody Energy class action lawsuit. Captioned McGeachy v. Peabody Energy Corporation, No. 26-cv-01020 (E.D. Mo.), the Peabody Energy class action lawsuit charges Peabody Energy as well as certain of Peabody Energy's top current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the Peabody Energy class action lawsuit, please provide your information here:
You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller by calling 800/851-7783 or via e-mail at [email protected].
CASE ALLEGATIONS: Peabody Energy engages in the production of metallurgical and thermal coal.
The Peabody Energy class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that they possessed reliable information pertaining to Peabody Energy's Centurion mine ramp-up and anticipated growth; and (ii) there was a multitude of issues causing delays to the Centurion mine ramp-up and the return to full longwall production dates.
On March 30, 2026, Peabody Energy issued a press release allegedly lowering guidance pertaining to Centurion mine's expected first quarter 2026 output by 450,000 tons ahead of Peabody Energy's full earnings release. On this news, the price of Peabody Energy stock fell nearly 10%, according to the complaint.
Then, on May 5, 2026, Peabody Energy issued a press release allegedly disclosing Peabody Energy's failure to ramp-up Centurion by the long-awaited March 2026 deadline and that Peabody Energy was cutting guidance related to full year met segment volumes to reflect the increased cost and substantial volume decrease. On this news, the price of Peabody Energy stock fell nearly 6%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Peabody Energy common stock during the Class Period to seek appointment as lead plaintiff in the Peabody Energy class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Peabody Energy class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Peabody Energy class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Peabody Energy class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors - $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever - $7.2 billion - in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Peabody Energy Corporation (“Peabody” or the “Company”) (NYSE: BTU) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PEABODY ENERGY CORPORATION (BTU), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal righ.
Alcoa Corporation has dropped over 40% since May 2026, but I remain bullish with a potential 42% upside. AA's recent acquisition of South32 assets strengthens its upstream aluminum position and is expected to generate ~$900M in NPV synergies. Despite macro headwinds and a sharp aluminum price correction, AA trades at less than 4x forward EV/EBITDA, well below its 5-year average.
PARIS--(BUSINESS WIRE)--Please replace the release with the following corrected version to add the Forward-Looking Statements paragraph at the end of the release. The updated release reads: COSTAR GROUP ANNOUNCES LAUNCH OF COSTAR PLATFORM IN FRANCE Empowering investors, brokers, owners, and occupiers with the data and analytics needed to succeed in France's estimated €300 billion commercial real estate market CoStar Group (NASDAQ: CSGP), an S&P 500 company and the global leader in real esta.
Please replace the release with the following corrected version to add the Forward-Looking Statements paragraph at the end of the release. The updated releas
Pre-Market Stock Futures: Futures are trading higher as we get ready to end the holiday-shortened trading week, with the country preparing to celebrate the 250th birthday of our democratic republic. The stock market will be closed on Friday for the federal holiday, kicking off a long weekend to jump-start the holiday fun. All of the major indices closed lower on Wednesday, with the Nasdaq leading the way, trading down 0.66% at 26,040, while the S&P 500 was last seen at 7,483, down 0.22%. The Dow Jones Industrials also closed lower at 52,305, down a tiny 0.03%, while printing a new all-time high earlier in the day. The small-cap-laden Russell 2000 finished the session down 0.39% at 3,012. The small-cap index leads all the major indices as we start the second half of the trading year, up over 20%.
Treasury Bonds: Yields were mixed across the Treasury curve to start July, with the belly and the long end selling off while buyers focused on the shorter T-bill maturities. When trading ended on Wednesday, the 30-year-long bond was last seen at 4.97%, while the benchmark 10-year note closed at 4.48%. Traders were focused on the commentary from the new Federal Reserve Chairman, Kevin Warsh, who noted that while economic conditions are good and improving as energy prices fall, inflation remains well above the 2% target.
Oil and Gas: In a bright note for consumers, as we start the third quarter, energy prices fell on Wednesday, with both of the major benchmarks finishing the session lower. Improving traffic in the Strait of Hormuz and the absence of new incidents between the U.S. and Iran remain positives for the energy complex. Brent Crude ended the day at $71.18, down 2.43%, while West Texas Intermediate closed trading at $68.10, down 2.03%. Natural gas also closed lower, finishing the day at $3.21, down 2.14%.
Gold: After a brutal second quarter, Gold started July off the right way, finishing the day up 0.59% at $4.030. Silver also had a winning day to start July, closing at $59.22, up 0.87%. Central banks, which were recently surveyed, expect gold to trade between $5,000 and $6,000 over the next year as they continue to purchase massive amounts to counter currency and other risk factors.
Crypto: Cryptocurrencies rallied on Wednesday in a broad-based relief rally, with the global crypto market capitalization rising roughly 0.5% to around $2.15 trillion. Major digital assets recovered significant ground after Federal Reserve Chair Kevin Warsh signaled that inflation risks are easing. At 8 AM EDT, Bitcoin is trading at $60,069, while Ethereum is quoted at $1,616.
24/7 Wall St. reviews dozens of analyst research reports every day to identify fresh investment ideas for investors and traders alike. These daily analyst notes include recommendations on stocks to buy, sell, or avoid, as well as new coverage initiations. Important reminder: No single analyst report should ever be the sole basis for buying or selling a stock.
Here are some of the best Wall Street analyst upgrades, downgrades, and initiations seen on Thursday, July 2, 2026.
Upgrades: Adobe (NASDAQ: ADBE | ADBE Price Prediction) was upgraded to Buy from Hold at HSBC, which raised the target price for the shares to $308 from $282. Chevron (NYSE: CVX) was upgraded to Outperform from Peer Perform at Wolfe Research, with a $210 target price. Palantir Technologies (NASDAQ: PLTR) was raised to Buy from Neutral at DA Davidson, with a $175 target price. Silicom (NASDAQ: SILC) was upgraded to Buy from Hold at Needham, which has a $60 target price. Downgrades: Agnt (NASDAQ: AGNT) was downgraded to Neutral from Buy at DA Davidson, which cut the target price to $6.50 from $10.25. Dana (NYSE: DAN) was downgraded to Equal Weight from Overweight at Barclays, with a $32 target price. Greenbrier Companies (NYSE: GBX) was cut to Neutral from Positive at Susquehanna, with a $52 target price. SkyWest (NASDAQ: SKYW) was downgraded to Neutral from Buy at Goldman Sachs, which trimmed the target price for the shares to $108 from $126. Trip.com Group (NASDAQ: TCOM) was cut to Hold from Buy at China Renaissance, with a $42 target price. Initiations: Honeywell Aerospace (NASDAQ: HONA) was initiated with an Outperform rating at BMO Capital, which has a $276 target price. Mobility Global (NASDAQ: MBGL) was started with a Sector Perform rating at RBC Capital, with a $23 target. Ni Source (NYSE: NI) was initiated with an Outperform rating at RBC Capital, which has a $52 target price.
OnHolding (NASDAQ: ONON) was resumed with an Overweight rating at JPMorgan, which has a $51 target price for the shares. Space Exploration Technologies (NASDAQ: SPCX) was started with a Neutral rating at Daiwa, with a $175 target price. Want Up To $1,000? SoFi Is Giving New Active Invest Users Free StockLooking to grow your money but unsure where to begin? SoFi Active Invest is offering a limited-time promotion—open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts.
From $0 commission trading to fractional shares and automated investing, this app is designed to simplify investing for everyone, whether you’re just starting or already experienced. Its easy to sign up and secure your bonus.
Rayonier is rated a hold post-PotlatchDeltic merger, with favorable upside but muted market sentiment and integration risks. RYN's vast, geographically diverse timberland portfolio offers long-term land appreciation potential, yet revenue and EBITDA margin trends remain weak. Dividend yield approaches 5%, but safety is questionable with a high payout ratio and 60% YoY FFO decline; growth is not compelling.
Varonis is positioned in the Customers' Choice Quadrant for DSPM, with 97% of customers willing to recommend July 02, 2026 09:00 ET | Source: Varonis Systems, Inc.
MIAMI, July 02, 2026 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the data and AI security leader, proudly announced it has been recognized by customers as a Gartner® Peer Insights™ Customers’ Choice for Data Security Posture Management (DSPM).
This recognition marks the third consecutive time Varonis earned this distinction. Varonis is also the only company to earn the Customers’ Choice recognition three years in a row in the DSPM category.
By being named a Customers' Choice, Varonis met or exceeded the market averages for Overall Experience and User Interest and Adoption. Varonis also received high ratings from customers in several categories:
97% of customers said they would recommend Varonis4.7/5 rating for Product Capabilities, Sales Expertise, and Deployment Experience4.9/5 rating in the Support Experience category What Varonis customers are saying
Customers consistently highlight Varonis’ breadth of coverage, ease of value realization, and strength of Varonis’ support.
Recent feedback from verified users on Gartner Peer Insights includes:
“Our experience with Varonis has been excellent. The solution provides high visibility into the data, significantly strengthens our security posture, and fully meets our demands. It also stands out for the quality and speed of the support provided.” – Read the review.
“One of the best products out there for Data Governance. Varonis has helped us with a plethora of projects and supports long-term audit success. Representative is great to work with!” – Read the review.
“Our experience with Varonis has been exceptional. From reducing our attack surface by mitigating overly permissive permissions to the amazing support they give to their product.” – Read the review.
Why securing data is critical for deploying and using AI
As organizations race to adopt AI, customers consistently turn to Varonis to secure and govern the data that fuels it, helping ensure models and agents can be deployed securely.
“Data security has never been more critical for organizations, especially as AI becomes central to business,” said Rob Sobers, CMO at Varonis. “Our customers are protecting sensitive information and advancing AI initiatives with confidence. We’re proud to be named a Customers’ Choice for the third straight year, and even prouder of the trust our customers place in us.”
Source: Gartner, Voice of the Customer for Data Security Posture Management, Peer Community Contributor, June 30, 2026.
Gartner and Peer Insights are trademarks of Gartner, Inc., and/or its affiliates.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
Additional Resources
Read more on the Varonis blog.See Varonis in action: schedule a 30-minute demo.For more information on Varonis' solutions, visit https://www.varonis.com.Visit our blog and join the conversation on LinkedIn and YouTube. About Varonis
Varonis (Nasdaq: VRNS) secures AI and the data that powers it. The Varonis platform gives organizations automated visibility and control over their critical data wherever it lives and helps ensure safe and trustworthy AI from code to runtime. Backed by 24x7x365 managed detection and response, Varonis gives thousands of organizations worldwide the confidence to adopt AI, reduce data exposure, and stop AI-powered threats.
Investor Relations Contact:
Tim Perz
Varonis Systems, Inc.
646-640-2112 [email protected]
News Media Contact:
Rachel Hunt
Varonis Systems, Inc.
877-292-8767 (ext. 1598) [email protected]
, /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing, will report financial and operating results for the quarter ended June 30, 2026, after the market closes on Thursday, July 30, 2026. A conference call for investors and analysts will be held at 9 a.m. Eastern on Friday, July 31, 2026. President and Chief Executive Officer J. Christopher Donahue and Chief Financial Officer Thomas R. Donahue will host the call.
Investors interested in listening to the conference call should dial 877-545-0523 (domestic) or 973-528-0016 (international) or visit FederatedHermes.com/us for real-time internet access. To listen online, go to the About section of the website to register and join the call.
A telephone replay of the call will begin at approximately 12:30 p.m. Eastern on July 31, 2026. To access the telephone replay, dial 877-481-4010 (domestic) or 919-882-2331 (international) and enter the access code 54241. The online replay will be available via FederatedHermes.com/us for one year.
Federated Hermes, Inc. is a global leader in active investment management, with $907.1 billion in assets under management, as of March 31, 2026. We deliver investment solutions that help investors target a broad range of outcomes and provide equity, fixed-income, alternative/private markets, multi-asset and liquidity management strategies to more than 11,000 institutions and intermediaries worldwide. Our clients include corporations, government entities, insurance companies, foundations and endowments, banks and broker/dealers. Headquartered in Pittsburgh, Federated Hermes has more than 2,000 employees in London, New York, Boston and offices worldwide. For more information, visit FederatedHermes.com/us.
As a member of the OpenAI Daybreak Cyber Partner Program, Cognizant brings the services, security expertise and implementation scale to help enterprises move frontier AI capability into production-grade defense.
, /PRNewswire/ -- Cognizant (Nasdaq: CTSH) today announced it is applying GPT-5.5 with Trusted Access for Cyber, through its Frontier AI Cyber Defense services, to help enterprises move faster from vulnerability discovery to validated, tested fixes. As a member of the OpenAI Daybreak Cyber Partner Program, Cognizant is putting frontier AI capability into its security experts' hands, helping strengthen how clients defend the software they build and operate.
Frontier AI is changing the economics of cyber defense. AI can now help surface vulnerabilities across large, complex codebases with greater speed and scale. But discovery is only the beginning. Protecting the enterprise depends on what comes next: validating which findings are real, understanding their impact, developing and testing a patch and landing the fix before an attacker can act.
The remediation gap is where enterprises must focus their efforts, and where Cognizant has the domain and institutional depth to help deliver, bringing a cybersecurity practice built over more than a decade, with 5,000+ security professionals. Cognizant's deep experience across regulated industries is intended to give clients the institutional muscle to put frontier capability to work at scale.
"Frontier AI has changed the equation for cyber defense, but a model's power only matters in how it is applied inside a real enterprise," said Sandra Notardonato, Global Head of Partner Development and Influencer Relations, Cognizant. "That is where Cognizant's AI Builder approach is designed to deliver. Our security teams bring these capabilities into our clients' code and security operations, helping them move from finding exposures to validating and remediating them. The advantage belongs to defenders who can pair frontier capability with the people and context to apply it responsibly, and that is what we aim to deliver at enterprise scale."
Through its Frontier AI Cyber Defense services, Cognizant's security professionals apply GPT-5.5 with Trusted Access for Cyber across authorized defensive workflows, including secure code review, threat modeling, vulnerability discovery and validation, detection engineering, threat hunting, and incident investigation and response. These capabilities are designed to embed into the workflows clients already run, with human validation and oversight at every step. They augment the deterministic controls and monitoring enterprises depend on rather than replacing them, accelerating the path from finding to fix while keeping defenders in control.
"Frontier cyber capability reaches more defenders when partners can operationalize it inside the trusted workflows enterprises already use every day," said Colleen Kapase, Vice President of Strategic Global Partnerships and Ecosystems, OpenAI. "Cognizant brings cybersecurity domain depth and delivery scale to help enterprises apply these capabilities responsibly, with the oversight and governance required to move from discovery to validated remediation."
Cognizant applies these capabilities within its own security operations before bringing them to clients, operating as its own Client Zero. Its security teams use GPT-5.5 with Trusted Access for Cyber across internal defensive workflows, including secure code review, vulnerability triage and validation and pull-request and CI/CD security review, with human validation and oversight at every step.
In its own environment, Cognizant is applying these capabilities across its estate of products, platforms and internal repositories to accelerate the lifecycle of vulnerability management from discovery to validation through remediation. This operational experience, earned on its own estate, is what Cognizant brings to client engagements.
Cognizant and OpenAI are working together within a framework built for responsible deployment, with scoped access, monitoring and human oversight designed to keep these capabilities in the hands of trusted defenders. It is the foundation for an expanding collaboration, as both companies work to bring frontier cyber defense to more enterprises.
About Cognizant
Cognizant (Nasdaq: CTSH) is an AI Builder and technology services provider, bridging the gap between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization's unique context into technology systems that amplify human potential, drive tangible outcomes and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant.
NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) ("APi" or the "Company") announced that on July 1, 2026, it closed the acquisition of WTech Fire Group ("WTech"), a leading provider of fire sprinkler, suppression and detection solutions across Europe. The acquisition, previously announced on April 17, 2026, adds highly complementary fire sprinkler and suppression capabilities to APi's international business. WTech is expected to contribute approximately $175 million in an.
APi Group Corporation (NYSE: APG) ("APi" or the "Company") announced that on July 1, 2026, it closed the acquisition of WTech Fire Group ("WTech"), a leading p
~ Updated clearance incorporates various instrument upgrades, as well as per-procedure costs, improving unit economics driven by the reclassification of certain instruments from disposable to reusable status ~
~ Clearance reflects Tenon's commitment to continuous innovation and operational efficiency, with reusable instrumentation expected to drive lower capex and logistical spend, contributing positively to gross margins and cash flow ~
LOS GATOS, CA / ACCESS Newswire / July 2, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Catamaran® SI Joint Fusion System.
The updated clearance incorporates various instrument upgrades, as well as the reclassification of certain instruments from disposable to reusable status. These enhancements are designed to further improve the performance of the Catamaran System while delivering meaningful economic benefits to the Company by eliminating ongoing per-procedure costs previously associated with disposable instrumentation.
"This 510(k) clearance reflects our ongoing commitment to never-ending refinement of our Catamaran System - not only for the physicians who rely on it and the patients who depend on it, but also for the long-term financial health of our business," said Steven M. Foster, President and CEO of Tenon. "The instrument upgrades advance the procedural performance that our surgeon users have come to expect from the Catamaran platform, and the transition of select instruments from disposable to reusable status is a smart operational improvement that will reduce our per-procedure cost structure and contribute positively to our gross margins going forward. As we continue to drive commercial adoption across our growing portfolio, initiatives like this demonstrate that we are focused on building a sustainable, scalable business."
The Catamaran SI Joint Fusion System offers a novel, minimally invasive approach to the sacroiliac joint, utilizing a single, robust titanium implant that stabilizes and transfixes the SI joint along its longitudinal axis. The implant's inferior-posterior surgical approach is designed to navigate away from critical neural and vascular structures and into the strongest cortical bone. Since its national launch in October 2022, there have been over 1,500 Catamaran Fixation Devices implanted in patients throughout the United States suffering from sacroiliac joint disruptions and degenerative sacroiliitis.
About Tenon Medical, Inc.
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran™ SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially all of the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
For more information, please visit www.tenonmed.com. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, SImmetry® are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+ are also trademarks of Tenon Medical, Inc.
Safe Harbor
This press release contains "forward-looking statements," which are statements related to events, results, activities or developments that Tenon expects, believes or anticipates will or may occur in the future. Forward-looking often contains words such as "intends," "estimates," "anticipates," "hopes," "projects," "plans," "expects," "seek," "believes," "see," "should," "will," "would," "target," and similar expressions and the negative versions thereof. These forward-looking statements, include, but are not limited to, statements regarding the completion of the Offering, the satisfaction of customary closing conditions related to the Offering and the anticipated use of proceeds therefrom. Such statements are based on Tenon's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made. Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause Tenon's actual results to be materially different than those expressed in any forward-looking statements, please review Tenon's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and updated from time to time in our Form 10-Q filings and in our other public filings on file with the SEC at www.sec.gov statements contain, particularly the information contained in the section entitled "Risk Factors." We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.
IR Contact:
Shannon Devine
203-741-8811
MZ North America [email protected]
WOBURN, MA / ACCESS Newswire / July 2, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered product discovery and eCommerce solutions, today announced that its HawkSearch platform has been ranked #1 in the B2B Search use case in the Critical Capabilities for Search and Product Discovery 2026 report. This marks the second consecutive year HawkSearch has achieved the highest ranking.
, /PRNewswire/ -- Hagens Berman (HBSS), a securities litigation leader, is broadening its investigation into Verra Mobility Corp. (NASDAQ: VRRM) following the company's disclosure of an abrupt leadership transition. The news comes in the wake of a securities action suit stemming from the catastrophic loss of a major contract.
VRRM Investors Submit Your Losses Now to HBSS
Class Period: Feb. 24, 2026 – May 26, 2026
Lead Plaintiff Deadline: Aug. 4, 2026
Visit: www.hbsslaw.com/investor-fraud/vrrm
Contact the Firm Now: [email protected]
844-916-0895
Leadership Vacuum
On June 1, 2026, Verra Mobility announced that long-time CEO David Roberts has abruptly stepped down, ending a 12-year tenure. This departure follows a volatile period for the company, initiated by the unexpected termination of a key contract with Avis Budget Group—a move that wiped out approximately $1.4 billion in shareholder value.
The Board of Directors has appointed former Chief Transformation and Legal Officer Jon Keyser as interim President and CEO while retaining a global search firm for a permanent replacement. Hagens Berman is investigating whether the departure is causally related to the allegations in the securities class action suit.
Verra Mobility Corporation (VRRM) Securities Class Action:
The complaint alleges Verra made false and misleading statements and did not disclose important information to investors about the true state of the Verra/Avis relationship and the likelihood of Verra receiving an Avis contract renewal.
The truth allegedly emerged on May 26, 2026, when Verra disclosed that it received a termination notice effective September 2026 from Avis regarding the companies' contract, that it is taking immediate actions to cut costs, adapt operations, and reposition its business, and revised its 2026 outlook that significantly deviated from that given just twenty days prior.
Verra also revealed that it was reviewing the parties' negotiations and handling of confidential information.
The news promptly sent the price of Verra shares 70% crashing lower on May 27, 2026, amputating $1.4 billion from the company's market capitalization in a single day.
View our latest video summary of the allegations: youtu.be/FVEw5XACoGA
"Our investigation is focused on the extent to which and when Verra and its executives knew that renegotiations with Avis were far from constructive, as the May 26 surprise reveals," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation.
If you invested in Verra and have substantial losses, or have knowledge that will assist the firm's investigation, submit your losses now.
If you'd like more information and answers to other frequently asked questions about the Verra case and the firm's investigation, read more.
Whistleblowers: Persons with non-public information regarding Verra should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Metalsource Mining Inc. (CSE: MSM) (OTCQB: MSMMF) (FSE: E9Z) ("Metalsource" or the "Company") is pleased to announce the strategic expansion of its Silver Hill land package through the execution of option agreements covering three additional properties totaling approximately 141 acres. The acquisitions increase the Company's consolidated land position to approximately 1,300 acres and secures prospective areas interpreted to be along strike and down dip of known mineralization. The transactions represent another important step in Metalsource's strategy to systematically expand the Silver Hill district as ongoing drilling, geophysics and geological interpretation continue to strengthen management's understanding of the broader exploration opportunity.
Management will continue evaluating strategic land acquisition opportunities that align with its evolving geological model, strengthening the Company's ability to systematically explore and unlock the broader potential of Silver Hill.
Highlights
Land position expanded to approximately 1,300 acres through option agreements covering three additional properties.
Newly acquired ground is interpreted to be along strike and down dip of known mineralization and part of the evolving Silver Hill geological model.
Expansion supports the Company's objective of evaluating the broader district scale potential beyond the historic mine footprint.
Exploration continues across Silver Hill with multiple assays pending while management advances plans to increase drilling capacity.
Figure 1: Plan view of existing property (yellow) with additional property additions (red). Note: Coordinate system in coordinates in WGS84 / UTMZ17N
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/12035/303699_cf8f383dd4c1998b_002full.jpg
Joe Cullen, CEO of Metalsource Mining, commented:
"This is a strategic acquisition we've been working toward for some time. As drilling, geophysics and geological interpretation have continued to improve our understanding of the Silver Hill system, it became increasingly important to secure these highly prospective properties while the opportunity was available. We're grateful to the families who have owned this land for generations and appreciate the trust they've placed in our team. Every successful drill hole has strengthened our confidence in the broader district and helped define where we believe the next phase of exploration should be focused. These newly acquired properties provide access to compelling exploration targets that we look forward to advancing in the near term as we continue expanding the known mineralized footprint at Silver Hill.
"As we move closer to increasing drilling capacity, our vision is clear: one program focused on systematically expanding the Silver Hill proper, while additional drilling evaluates high priority regional targets generated through our geological work and recent IP surveys. We believe we're still in the early stages of understanding the scale of this district, and we're excited by the potential for both resource expansion and new discoveries."
What's Next
Multiple assays pending from the current drill campaign, with results expected to continue advancing the Company's understanding of the Silver Hill system. Increasing drilling capacity as management advances plans to secure an additional drill rig to accelerate testing of both known mineralization and newly identified exploration targets. Testing the broader district through continued integration of drilling, IP geophysics and geological interpretation to prioritize additional targets beyond the historic mine footprint. Continuing strategic growth through evaluation of additional land opportunities that complement the Company's evolving district scale exploration strategy.Why This Matters to Investors
The expansion of the Silver Hill land package reflects management's growing confidence in the broader exploration potential of the district. As drilling, geological interpretation and property scale geophysical surveys continue to refine the Company's understanding of the system, Metalsource is strategically securing prospective ground that may host mineralization and additional high priority exploration targets.
The newly acquired properties are expected to play an important role in the next phase of exploration. While the current drill program continues to systematically expand the known Silver Hill deposit, these acquisitions position the Company to evaluate a growing pipeline of prospective targets across the broader district as additional drilling capacity comes online.
With multiple drill holes pending, plans to accelerate exploration and an expanding portfolio of high priority targets, Metalsource believes it is transitioning from exploring a historic mine to systematically unlocking the broader district scale potential of one of America's most historically significant polymetallic mining camps.
Qualified Person
All scientific and technical information has been reviewed and approved by Darcy Vis, B.Sc., P.Geo., President of Tripoint Geological Services Ltd., a contractor of the Company, and a Qualified Person as defined under National Instrument ("NI") 43-101 - Standards of Disclosure for Mineral Projects.
Silver Hill Project
Located in the Carolina Terrane, the property is underlain by volcaniclastic and volcano-sedimentary rocks predominantly of Neoproterozoic and Cambrian age. Current interpretations suggest this terrane is an extension of the Avalon Terrane. The property is 1,225 acres located in Davidson County, North Carolina. As the first significant discovery and first silver-producing mine in America, the property is supported by an extensive historic dataset, including drillhole data, underground mapping, historic dumps and underground chip samples. Currently known mineralization extends to 550m from surface, in a steeply trending series of lenses, which remain open in multiple directions.
Byrd-Pilot Mountain Project
The Byrd-Pilot Mountain Project is located in central North Carolina within the Carolina Terrane. Initial USGS surveys in the 1980s identified the area as a potential host for a porphyry gold-copper system. Subsequent exploration demonstrated broad gold mineralization in soils, trenches, and shallow RC drilling, coincident with strong self-potential anomalies. Geology shows intense quartz-sericite-pyrite alteration, high-sulfidation signatures, and high-alumina minerals (like Haile and Brewer deposits to the south), suggesting potential for a large epithermal or porphyry-related gold system. Geologic modelling of currently identified mineralization indicates an east-west trend open in multiple directions, with oxidation noted down to a depth of 30m. No drilling has tested the Meridian discovery zone since those 1980s campaigns, leaving potential for significant resource expansion through work commitments of the agreement.
About Metalsource Mining Inc.
Metalsource Mining Inc. is a U.S.-focused precious and critical metals exploration company advancing the Silver Hill Project in North Carolina, widely recognized as America's first silver mine. A historically producing mining district dating back to 1839, Silver Hill produced silver, gold, lead and zinc during the formative years of the American mining industry and remains one of the most historically significant mining assets in the United States.
The Company is focused on expanding known mineralization, advancing toward a modern resource estimate, and unlocking the broader potential of the Silver Hill district through systematic drilling, geological modeling and modern exploration techniques.
Metalsource Mining
America's First Silver Mine. Modern Exploration. Historic Opportunity.
For further information, please contact:
Joe Cullen CEO - Metalsource Mining Inc.
Tel: (778) 919-8615
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/303699
Source: Metalsource Mining Inc.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 clinical trials evaluating zoldonrasib, its oral RAS(ON) G12D-selective covalent inhibitor, in combination regimens for patients with RAS G12D metastatic pancreatic ductal adenocarcinoma (PDAC). The results, which will be presented today in a proffered paper session at the 2026 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress, include zoldonrasib in combination with standard of care chemotherapy in previously untreated patients and zoldonrasib in combination with daraxonrasib, the company’s oral RAS(ON) multi-selective inhibitor, in previously treated patients.
“The Phase 3 RASolute 302 results provided clinical validation of RAS(ON) inhibition with daraxonrasib in second line metastatic pancreatic cancer and established a strong foundation for evaluating this therapeutic approach across additional RAS genotypes, treatment settings and combination strategies. The results presented at ESMO GI demonstrate compelling proof-of-concept for two zoldonrasib-based regimens in RAS G12D disease: combination with standard of care chemotherapy in previously untreated patients and a RAS(ON) inhibitor doublet with daraxonrasib in previously treated patients. Together, these findings are the foundation of two distinct Phase 3 strategies we are pursuing in previously untreated metastatic RAS G12D pancreatic cancer: the ongoing RASolute 305 trial evaluating zoldonrasib plus standard of care chemotherapy, and the planned RASolute 309 trial evaluating the combination of zoldonrasib plus daraxonrasib,” said Alan Sandler, M.D., chief development officer of Revolution Medicines.
Safety and Efficacy of Zoldonrasib Plus Chemotherapy in Patients with First Line RAS G12D Metastatic Pancreatic Cancer (Abstract #340O)
RMC-GI-102 (NCT06445062) is an ongoing Phase 1/2 trial evaluating zoldonrasib 1200 mg once daily in combination with investigator's choice of standard of care chemotherapy in patients with previously untreated metastatic RAS G12D PDAC. Investigator's choice of chemotherapy includes modified FOLFIRINOX (mFFX) or gemcitabine plus nab-paclitaxel (GnP). As of the February 8, 2026 data cutoff, the trial enrolled 41 patients in the zoldonrasib plus mFFX arm and 40 patients in the zoldonrasib plus GnP arm.
Zoldonrasib demonstrated a manageable safety and tolerability profile in combination with standard chemotherapy. The safety profile of zoldonrasib in combination with chemotherapy was broadly consistent with the established profiles of each respective chemotherapy regimen. Grade 3 or greater treatment-related adverse events (TRAEs) occurred in 61% of patients who received the zoldonrasib plus mFFX and 80% of patients who received zoldonrasib plus GnP. The most common Grade 3 or greater TRAEs with zoldonrasib plus mFFX were decreased neutrophil count (37%), anemia (12%), and platelet count decreased (7%). The most common Grade 3 or greater TRAEs with zoldonrasib plus GnP were decreased neutrophil count (35%), anemia (28%), and fatigue (25%). No Grade 5 TRAEs were reported in either arm. The mean dose intensity was 86% with zoldonrasib plus mFFX and 90% with the zoldonrasib plus GnP.
In the trial, zoldonrasib with chemotherapy showed compelling antitumor activity, with an objective response rate (ORR) of 82% (95% confidence interval [CI]: 60, 95) and disease control rate (DCR) of 96% (95% CI: 77, 100) in the mFFX population, and an ORR of 61% (95% CI: 42, 78) and DCR of 90% (95% CI: 74, 98) in the GnP population.
These preliminary safety and clinical activity data support the ongoing RASolute 305 pivotal trial (NCT07621718), a global, randomized, double-blind placebo-controlled Phase 3 clinical trial evaluating zoldonrasib plus investigator’s choice of standard of care chemotherapy compared with placebo plus investigator’s choice of chemotherapy in patients with previously untreated metastatic RAS G12D PDAC.
Safety and Efficacy of Zoldonrasib Plus Daraxonrasib in Patients with Second Line-Plus RAS G12D Metastatic Pancreatic Cancer (Abstract #341O)
RMC-9805-001 (NCT06040541) is a Phase 1 trial evaluating zoldonrasib 1200 mg once daily plus daraxonrasib 300 mg once daily in advanced solid tumors with RAS G12D mutations. As of the February 9, 2026 data cutoff, 60 patients with RAS G12D metastatic PDAC who had previously received one or more prior lines of therapy were treated with the combination.
Zoldonrasib plus daraxonrasib demonstrated a manageable safety and tolerability profile that was broadly consistent with the established profile of daraxonrasib monotherapy. Grade 3 or greater TRAEs occurred in 35% of patients who received the combination. Among TRAEs occurring in 10% or more of all patients, the most common Grade 3 or greater events were rash (12%), anemia (10%), and stomatitis/mucositis (7%). Few patients discontinued due to TRAES; 2% discontinued zoldonrasib and 5% discontinued daraxonrasib. The mean dose intensity was 88% for zoldonrasib and 76% for daraxonrasib.
The zoldonrasib plus daraxonrasib combination demonstrated compelling antitumor activity in patients with previously treated metastatic PDAC. In the second line cohort (2L) (N=30), the ORR was 50% (95% CI: 31–69) and DCR was 97% (95% CI: 83–100). Median progression-free survival (PFS) in the 2L cohort was 9.6 months (95% CI: 7.1–NE), with a 6-month PFS rate of 71%. Median overall survival (OS) in the 2L cohort was not yet estimable, with a 6-month OS rate of 89%. In the third line and beyond (3L+) cohort (N=30), the ORR was 47% (95% CI: 28–66) and DCR was 90% (95% CI: 74–98). Median PFS in the 3L+ cohort was 7.6 months (95% CI: 4.6–10.5), with a 6-month PFS rate of 59%. Median OS in the 3L+ cohort was 10.5 months (95% CI: 6.7–NE), with a 6-month OS rate of 82%.
These safety and clinical activity data support the planned pivotal global, Phase 3 RASolute 309 clinical trial of zoldonrasib plus daraxonrasib versus GnP in patients with previously untreated RAS G12D metastatic PDAC.
About Pancreatic Cancer and Pancreatic Ductal Adenocarcinoma
Pancreatic cancer is one of the most lethal malignancies, characterized by its typically late-stage diagnosis, resistance to standard chemotherapy, and high mortality rate. Pancreatic ductal adenocarcinoma, or PDAC, is the most common form of pancreatic cancer. Due to the lack of early symptoms and effective detection methods, approximately 80% of patients are diagnosed with advanced or metastatic disease. PDAC is the most commonly RAS-driven malignancy of all major cancers, with more than 90% of patients having tumors that harbor RAS mutations.1 RAS G12D is the most prevalent RAS mutation subtype in PDAC, occurring in 40% of patients, and has been associated with poorer outcomes than RAS wild-type disease and certain other RAS-mutant subgroups.1-4
About Zoldonrasib
Zoldonrasib is an investigational, oral RAS(ON) G12D-selective covalent tri-complex inhibitor. RAS G12D is the most prevalent RAS mutation, accounting for 29% of all RAS cancers.1 Across tumor types, approximately 61,000 new patients with RAS G12D cancers are estimated each year in the U.S., and no targeted therapy is currently approved for these patients.5 Zoldonrasib is currently being evaluated as a monotherapy and in combination with other therapies, including with Revolution Medicines’ RAS(ON) multi-selective inhibitor daraxonrasib (RMC-6236), as well as standard of care regimens in lung and gastrointestinal cancers.
About Daraxonrasib
Daraxonrasib is an investigational, oral RAS(ON) multi-selective, non-covalent tri-complex inhibitor. The U.S. Food and Drug Administration (FDA) granted daraxonrasib Breakthrough Therapy Designation and Orphan Drug Designation for the treatment of patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) harboring G12 mutations. In addition, daraxonrasib was selected for the FDA Commissioner’s National Priority Voucher pilot program, which is intended to accelerate the development and review of therapies aligned with U.S. national health priorities.
Daraxonrasib is designed to target cancers driven by a broad range of common RAS genotypes, including PDAC, non-small cell lung cancer (NSCLC), and colorectal cancer. Daraxonrasib is being advanced through a global Phase 3 registrational program comprising four trials, including the completed RASolute 302 trial and three additional trials in patients with PDAC and metastatic RAS mutant NSCLC.
About Revolution Medicines, Inc.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Additional development opportunities in the company’s pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit www.revmed.com and follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered “forward-looking statements,” including without limitation statements regarding our development strategy, including in RAS G12D pancreatic cancer; the potential of our product candidates for RAS(ON) inhibition, including in pancreatic cancer; the ability of daraxonrasib or zoldonrasib to improve patient outcomes; planned and ongoing clinical studies; and potential efficacy of the company’s product candidates being studied.
Forward-looking statements are typically, but not always, identified by the use of words such as “anticipate,” "estimate," "plan," “potential,” “proof-of-concept,” “pursuing,” "will" and other similar terminology indicating future results. Such forward-looking statements are subject to substantial risks and uncertainties that could cause the company’s development programs, future results, performance, or achievements to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include without limitation risks and uncertainties inherent in the drug development process, including the company’s programs’ development stages, the process of designing and conducting preclinical and clinical trials, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, the company’s ability to successfully establish, protect and defend its intellectual property, other matters that could affect the sufficiency of the company’s capital resources to fund operations, reliance on third parties for manufacturing and development efforts, changes in the competitive landscape, and the effects on the company’s business of the global events, such as international conflicts or global pandemics. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Revolution Medicines in general, see Revolution Medicines’ Annual Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on May 6, 2026, and its future periodic reports to be filed with the SEC. Except as required by law, Revolution Medicines undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances, or to reflect the occurrence of unanticipated events.
1 Lee JK, Sivakumar S, Schrock AB, et al. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors. NPJ Precis Oncol. 2022;6(1);91. doi:10.1038/s41698-022-00334-z
2 Yousef, A., Yousef, M., Chowdhury, S. et al. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. NPJ Precis Oncol. 2024;8:27. https://doi.org/10.1038/s41698-024-00505-0
3 Qian ZR, Rubinson DA, Nowak JA, et al. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2018;4(3):e173420. doi:10.1001/jamaoncol.2017.3420
4 Norton C, Shaw MS, Rubnitz Z, et al. KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. JAMA Netw Open. 2025;8(1):e2453588. doi:10.1001/jamanetworkopen.2024.53588
5 Estimated using tumor mutation frequencies from Foundation Medicine Insights March 2022 and scaled to estimated patient numbers using cancer incidence from ACS Cancer Facts and Figures 2023.
